Spondyloepimetaphyseal Dysplasia Strudwick Type

Mendelian MONDO:0008476 Pathograph 2 Type 2 Collagenopathy Spondyloepimetaphyseal Dysplasia

Spondyloepimetaphyseal dysplasia Strudwick type (SEMD Strudwick) is a rare autosomal dominant type II collagenopathy caused by heterozygous missense mutations in COL2A1, typically glycine substitutions within the Gly-X-Y triple-helical repeat. The disorder is characterized by disproportionate short-trunk short stature, progressive kyphoscoliosis, pectus carinatum, and distinctive dappled or flocculated metaphyseal changes on radiographs. Mutant type II procollagen is retained in the endoplasmic reticulum of chondrocytes, where it may trigger ER stress and the unfolded protein response or, in some variants, evade ER quality control entirely (failed cellular surveillance), in either case disrupting chondrocyte proliferation, differentiation, and endochondral ossification. Ocular involvement (high myopia, retinal detachment) reflects the role of type II collagen in vitreous humor, and premature osteoarthritis results from defective articular cartilage matrix. The condition was first described in the Strudwick family by Murdoch and Walker in 1969.

Ask OpenScientist

Ask a research question about Spondyloepimetaphyseal Dysplasia Strudwick Type. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
4
Pathophys.
17
Phenotypes
2
Pathograph
1
Genes
4
Treatments
2
Models
1
References
3
Deep Research
👪

Inheritance

1
Autosomal Dominant
Autosomal dominant inheritance. Both de novo and inherited cases occur. When an affected parent carries the mutation, each offspring has a 50% chance of inheriting it.
Show evidence (1 reference)
PMID:7550321 SUPPORT Human Clinical
"We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1."
Heterozygosity for COL2A1 mutations in three unrelated patients confirms autosomal dominant mechanism.
⚙

Pathophysiology

4
Collagen Triple Helix Disruption
Glycine-to-amino-acid substitutions in the Gly-X-Y repeats of the COL2A1 triple-helical domain destabilize the type II collagen triple helix through a dominant-negative mechanism. Because glycine is the only amino acid small enough to fit in the center of the triple helix, its substitution prevents proper chain folding. Even a single mutant alpha-1(II) chain incorporated into a trimeric molecule disrupts the entire structure, causing altered electrophoretic mobility, reduced thermostability, and slow secretion.
Chondrocyte link
COL2A1 link
Collagen Fibril Organization link Collagen Biosynthesis link
extracellular matrix structural constituent link
Show evidence (3 references)
PMID:7550321 SUPPORT Human Clinical
"We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1."
Biochemical characterization in three unrelated SEMD Strudwick patients established that heterozygous COL2A1 mutations produce abnormal alpha-1(II) collagen chains.
PMID:12925722 SUPPORT Human Clinical
"All previously reported autosomal dominant mutations causing SEMD have substituted an obligate glycine within the triple helix, in particular at codons 292, 304 and 709 in the three reported Strudwick-type patients."
Documents that all known SEMD Strudwick mutations substitute glycine residues within the triple helix, confirming the dominant-negative mechanism.
PMID:26443184 SUPPORT Human Clinical
"One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats of the alpha 1 chain. These mutations disrupt the collagen triple helix and are common in achondrogenesis type II and hypochondrogenesis."
Comprehensive review of 415 COL2A1 mutations confirms that glycine substitutions in the Gly-X-Y repeats produce dominant-negative effects disrupting the triple helix.
ER Retention and Impaired Procollagen Proteostasis
Misfolded type II procollagen molecules accumulate in the endoplasmic reticulum of chondrocytes, causing ER distention and an ER storage disorder phenotype. The cellular response to this accumulation is variant-dependent: some mutations activate canonical ER stress and the unfolded protein response (UPR), leading to chondrocyte apoptosis and growth plate disorganization. However, recent iPSC-derived cartilage models demonstrate that certain COL2A1 substitutions cause ER retention and defective matrix deposition without robust UPR activation, indicating a failure in cellular surveillance where misfolded procollagen evades ER quality control. Both pathways converge on reduced chondrocyte proliferation and compromised cartilage matrix.
Chondrocyte link Growth Plate Chondrocyte link
ER Unfolded Protein Response link Response to ER Stress link Chondrocyte Differentiation link
Show evidence (3 references)
PMID:25451152 SUPPORT Model Organism
"Our studies demonstrated that chondrocytes expressing the thermolabile R992C mutant collagen II molecules endured endoplasmic reticulum stress, had atypical polarization, and had reduced proliferation."
Conditional transgenic mouse model of SED demonstrates ER stress, atypical chondrocyte polarization, and reduced proliferation as direct consequences of mutant collagen II expression.
PMID:25187577 SUPPORT In Vitro
"The COL2pathy-iChon cells showed suppressed expression of COL2A1 and significant apoptosis. A distended endoplasmic reticulum (ER) was detected, thus suggesting the adaptation of gene expression and cell death caused by excess ER stress."
Patient-derived iPSC chondrocytes demonstrate ER distension, suppressed COL2A1 expression, and apoptosis, directly modeling the ER stress pathomechanism.
PMID:40602718 SUPPORT In Vitro
"Arg719Cys procollagen-II was excessively post-translationally modified and partially retained within the endoplasmic reticulum (ER), leading to ER distention. Notably, despite introduction of an aberrant cysteine residue-expected to engage redox-sensitive folding and quality control..."
Demonstrates that certain COL2A1 substitutions cause ER retention and matrix deficiency without canonical UPR activation, revealing a failed surveillance mechanism.
Disrupted Endochondral Ossification
The combined effects of ER stress-induced chondrocyte dysfunction, reduced proliferation, and premature apoptosis in the growth plate disrupt the normal sequence of endochondral ossification. Chondrocytes fail to organize into proper columns, and the progression from proliferative to hypertrophic zones is impaired. The resulting disorganized growth plate architecture underlies the characteristic skeletal abnormalities including short-trunk dwarfism, platyspondyly, and metaphyseal dysplasia.
Growth Plate Chondrocyte link Osteoblast link
Endochondral Ossification link Cartilage Development link Bone Development link
Show evidence (2 references)
PMID:25451152 SUPPORT Model Organism
"we analyzed the pathomechanisms responsible for growth alterations in transgenic mice with conditional expression of the R992C collagen II mutation. Specifically, we studied the alterations of the growth plates of mutant mice in which chondrocytes lacked their typical columnar arrangement."
Directly demonstrates that mutant collagen II expression disrupts growth plate columnar organization, a hallmark of impaired endochondral ossification.
PMID:7550321 SUPPORT Human Clinical
"Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen."
Growth plate abnormalities in SEMD Strudwick patients confirm disrupted endochondral ossification in human disease.
Defective Articular Cartilage Matrix
Type II collagen is the major structural protein of articular cartilage. Mutant collagen molecules that are secreted form abnormal fibrils with compromised mechanical properties. Combined with abnormal joint geometry from the skeletal dysplasia (coxa vara, genu valgum), this predisposes to accelerated cartilage degradation and premature osteoarthritis.
Chondrocyte link
Collagen Fibril Organization link
Show evidence (2 references)
PMID:18328979 SUPPORT Human Clinical
"epiphyseal dysplasia is often a predominant feature, and the course of the disease is marked by premature osteoarthritis"
Review of SEMD disorders confirms premature osteoarthritis as a hallmark complication related to epiphyseal cartilage defects.
PMID:12925722 SUPPORT Human Clinical
"the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"
Early-onset degenerative osteoarthrosis documented in a three-generation Strudwick family reflects the defective articular cartilage matrix.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Spondyloepimetaphyseal Dysplasia Strudwick Type Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

17
Eye 2
Myopia Myopia (HP:0000545)
Show evidence (2 references)
PMID:12925722 SUPPORT Human Clinical
"the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"
Myopia documented as a specific phenotypical feature in a three-generation family.
PMID:25383842 SUPPORT Human Clinical
"He was highly myopic and had a visual acuity of 20/80 in the right eye and counting fingers in the left eye."
Direct Strudwick retinal case report shows that the myopia can be high-grade.
Retinal Detachment Retinal detachment (HP:0000541)
Show evidence (1 reference)
PMID:25383842 SUPPORT Human Clinical
"A 13-year-old patient diagnosed with spondyloepimetaphyseal dysplasia-Strudwick type presented with a localized superior temporal retinal detachment in the right eye and a 180° giant retinal tear with an associated macula-off retinal detachment in the left eye."
Direct Strudwick case report documents bilateral rhegmatogenous retinal detachment in adolescence.
Limbs 6
Limb Undergrowth Limb undergrowth (HP:0009826)
Show evidence (2 references)
PMID:12925722 SUPPORT Human Clinical
"the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"
Direct Strudwick family report identifies limb shortening as part of the phenotype.
PMID:8723096 SUPPORT Human Clinical
"The skeletal radiographs showed an evolution from short tubular bones, delayed epiphyseal development, and mild vertebral involvement to severe metaphyseal dysplasia with dappling irregularities, and hip "dysplasia.""
Longitudinal radiographic follow-up in Gly154Arg SEMD cases, later cited as consistent with the Strudwick subtype, documents appendicular shortening.
Metaphyseal Dysplasia Metaphyseal dysplasia (HP:0100255)
Show evidence (3 references)
PMID:7550321 SUPPORT Human Clinical
"The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."
Dappled metaphyses are the key distinguishing feature of SEMD Strudwick versus SEDC.
PMID:17163530 SUPPORT Human Clinical
"A mild degree of metaphyseal dysplasia can be seen in the so-called Strudwick variant of spondyloepimetaphyseal dysplasia and is generally mild or absent in other forms."
Confirms metaphyseal dysplasia as a defining feature of the Strudwick variant of SEMD.
PMID:1870932 SUPPORT Human Clinical
"The distinguishing radiologic feature of this condition is the striking irregularity of long bone metaphyses which develops during infancy."
Classic Strudwick case report directly supports infantile onset of the hallmark metaphyseal irregularity.
Context-specific annotations (1)
Onset: INFANTILE
Show evidence (1 reference)
PMID:1870932 SUPPORT Human Clinical
"The distinguishing radiologic feature of this condition is the striking irregularity of long bone metaphyses which develops during infancy."
Supports infantile onset of the hallmark metaphyseal irregularity.
Coxa Vara Coxa vara (HP:0002812)
Show evidence (2 references)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Coxa vara documented as an orthopaedic manifestation in SEMD Strudwick.
PMID:1870932 SUPPORT Human Clinical
"Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis."
Classic radiology case documents coxa vara in congenital Strudwick presentation.
Genu Valgum Genu valgum (HP:0002857)
Show evidence (1 reference)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Genu valgum documented as a lower limb malalignment manifestation in SEMD Strudwick.
Hip Subluxation Hip subluxation (HP:0030043)
Show evidence (1 reference)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Hip subluxation documented as an orthopaedic manifestation in SEMD Strudwick.
Talipes Equinovarus Talipes equinovarus (HP:0001762)
Show evidence (1 reference)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Club foot documented as a lower limb malalignment manifestation in SEMD Strudwick.
Musculoskeletal 8
Scoliosis Scoliosis (HP:0002650)
Show evidence (1 reference)
PMID:7550321 SUPPORT Human Clinical
"The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."
Scoliosis is one of the characteristic features of SEMD Strudwick.
Kyphosis Kyphosis (HP:0002808)
Show evidence (1 reference)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Severe kyphosis documented as an orthopaedic manifestation of SEMD Strudwick.
Hyperlordosis Hyperlordosis (HP:0003307)
Show evidence (2 references)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Lordosis of dorsal and lumbar spines documented in SEMD Strudwick patients.
PMID:1870932 SUPPORT Human Clinical
"Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis."
Classic radiology case report documents lumbar lordosis from birth.
Pectus Carinatum Pectus carinatum (HP:0000768)
Show evidence (1 reference)
PMID:7550321 SUPPORT Human Clinical
"The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."
Pectus carinatum is a characteristic feature of SEMD Strudwick.
Delayed Epiphyseal Ossification Delayed epiphyseal ossification (HP:0002663)
Show evidence (2 references)
PMID:1870932 SUPPORT Human Clinical
"Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis."
Direct Strudwick case report documents delayed ossification of the proximal femoral epiphyses at birth.
PMID:8723096 SUPPORT Human Clinical
"The skeletal radiographs showed an evolution from short tubular bones, delayed epiphyseal development, and mild vertebral involvement to severe metaphyseal dysplasia with dappling irregularities, and hip "dysplasia.""
Longitudinal Gly154Arg SEMD cases document delayed epiphyseal development during follow-up.
Context-specific annotations (1)
Onset: CONGENITAL
Show evidence (1 reference)
PMID:1870932 SUPPORT Human Clinical
"Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis."
Supports congenital onset of delayed proximal femoral epiphyseal ossification.
Atlantoaxial Instability Atlantoaxial instability (HP:0003467)
Show evidence (1 reference)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Atlantoaxial instability with hypoplastic odontoid peg documented in SEMD Strudwick patients.
Hypoplasia of the Odontoid Process Hypoplasia of the odontoid process (HP:0003311)
Show evidence (2 references)
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Hypoplastic odontoid peg documented as an orthopaedic manifestation in SEMD Strudwick.
PMID:1870932 SUPPORT Human Clinical
"Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis."
Classic Strudwick case report documents odontoid hypoplasia at birth.
Early-Onset Osteoarthritis Osteoarthritis (HP:0002758)
Show evidence (2 references)
PMID:12925722 SUPPORT Human Clinical
"the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis"
Early-onset degenerative osteoarthrosis documented as a specific phenotypical feature.
PMID:16280719 SUPPORT Human Clinical
"The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot."
Early severe hip osteoarthritis documented with 30-year follow-up.
Growth 1
Disproportionate Short-Trunk Short Stature Disproportionate short-trunk short stature (HP:0003521)
Show evidence (1 reference)
PMID:7550321 SUPPORT Human Clinical
"The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC)."
Disproportionate short stature is one of the defining features of SEMD Strudwick.
🧬

Genetic Associations

1
COL2A1 (Causative)
Show evidence (4 references)
PMID:7550321 SUPPORT Human Clinical
"We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1."
Landmark paper establishing that heterozygous COL2A1 mutations cause SEMD Strudwick through biochemical characterization in three unrelated patients.
PMID:12925722 SUPPORT Human Clinical
"A point mutation within exon 20 of the COL2A1 gene was identified that substituted a glycine for an aspartic acid residue at codon 262."
Identifies a novel Gly262Asp mutation in a three-generation family, extending the mutational spectrum.
PMID:26443184 SUPPORT Human Clinical
"Over 700 patients were recorded, harboring 415 different mutations. One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats of the alpha 1 chain."
Comprehensive mutation database review establishes glycine substitutions as the major class of dominant-negative COL2A1 mutations across type II collagenopathies.
+ 1 more reference
💊

Treatments

4
Orthopedic Surveillance and Surgery
Action: Orthopedic surgery Ontology label: surgical procedure MAXO:0000004
Management of progressive scoliosis and kyphosis (bracing, spinal fusion when severe), correction of limb deformities (osteotomy for coxa vara and genu valgum), hip arthroplasty for severe osteoarthritis, and monitoring for atlantoaxial instability with surgical stabilization if needed.
Show evidence (2 references)
PMID:16280719 SUPPORT Human Clinical
"We report a mother and daughter with SEMD Strudwick Type and describe their orthopaedic problems, surgical management and clinical outcome after 30 years and 7 years of follow-up respectively."
Long-term follow-up documents the orthopedic surgical interventions required in SEMD Strudwick patients.
PMID:25604898 SUPPORT Human Clinical
"Over 50% of the patients had undergone orthopedic surgery, usually for scoliosis, femoral osteotomy or hip replacement."
Large cohort demonstrates that over half of COL2A1 patients require orthopedic surgery.
Ophthalmologic Surveillance
Regular ophthalmologic evaluation for myopia progression and retinal detachment screening. Type II collagen abnormalities in the vitreous create ongoing risk for retinal complications.
Physical Therapy and Orthotic Devices
Action: Orthotic device usage Ontology label: orthotic device usage MAXO:0000482
Rehabilitation and orthotic support to manage mobility limitations and prevent progressive deformity.
Pulmonary Monitoring
Monitoring for restrictive lung disease secondary to severe kyphoscoliosis. Non-invasive ventilation support may be required when respiratory compromise develops.
🧫

Experimental Models

2
COL2A1 patient-derived iPSC chondrocytes IPSC_DERIVED_MODEL
Fibroblasts from type II collagenopathy patients were directly converted to induced chondrogenic (iChon) cells and also reprogrammed to iPSCs then differentiated to chondrocytes. Both systems showed distended ER, suppressed COL2A1 expression, and significant apoptosis. Chemical chaperone treatment partially rescued apoptosis and increased collagen secretion, providing a drug screening platform.
Chondrocyte ↗
Organism
human ↗
Publication
PMID:25187577 ↗
Isogenic COL2A1 Arg719Cys iPSC-derived cartilage IPSC_DERIVED_MODEL
Isogenic iPSC lines carrying the Arg719Cys COL2A1 substitution were differentiated into chondrocytes and cartilage tissues. Mutant tissues displayed a deficient collagen-II matrix, ER distention with intracellular procollagen retention, and excessive post-translational modification. The mutant procollagen was not recognized by the ER proteostasis network and the unfolded protein response was not activated, demonstrating a failure in cellular surveillance that allows secretion of defective collagen and pathogenic matrix deposition.
Chondrocyte ↗
Organism
human ↗
Publication
PMID:40602718 ↗
{ }

Source YAML

click to show 
name: Spondyloepimetaphyseal Dysplasia Strudwick Type
creation_date: '2026-02-06T03:25:37Z'
updated_date: '2026-04-19T07:03:05Z'
category: Mendelian
description: >
  Spondyloepimetaphyseal dysplasia Strudwick type (SEMD Strudwick) is a rare
  autosomal dominant type II collagenopathy caused by heterozygous missense
  mutations in COL2A1, typically glycine substitutions within the Gly-X-Y
  triple-helical repeat. The disorder is characterized by disproportionate
  short-trunk short stature, progressive kyphoscoliosis, pectus carinatum,
  and distinctive dappled or flocculated metaphyseal changes on
  radiographs. Mutant type II procollagen is retained in the endoplasmic
  reticulum of chondrocytes, where it may trigger ER stress and the unfolded
  protein response or, in some variants, evade ER quality control entirely
  (failed cellular surveillance), in either case disrupting chondrocyte
  proliferation, differentiation, and endochondral ossification.
  Ocular involvement (high myopia, retinal detachment) reflects the role of
  type II collagen in vitreous humor, and premature osteoarthritis results from
  defective articular cartilage matrix. The condition was first described in
  the Strudwick family by Murdoch and Walker in 1969.
disease_term:
  preferred_term: spondyloepimetaphyseal dysplasia Strudwick type
  term:
    id: MONDO:0008476
    label: spondyloepimetaphyseal dysplasia, Strudwick type
parents:
- Type 2 Collagenopathy
- Spondyloepimetaphyseal Dysplasia
inheritance:
- name: Autosomal Dominant
  description: >
    Autosomal dominant inheritance. Both de novo and inherited cases occur.
    When an affected parent carries the mutation, each offspring has a 50%
    chance of inheriting it.
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1.
    explanation: >-
      Heterozygosity for COL2A1 mutations in three unrelated patients confirms autosomal dominant mechanism.
prevalence:
- population: Published literature cohorts worldwide
  percentage: Unknown
  notes: >-
    No population-based prevalence studies exist. The literature consists of
    individual case reports and small family studies. The classic molecular
    paper cites a prior series of 14 patients. In a 93-patient COL2A1 cohort,
    5 had SEMD.
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phenotype was first described by Murdoch and Walker in 1969, and a series of 14 patients was later reported by Anderson et al.
    explanation: >-
      Provides the clearest summary of the limited number of historically reported SEMD Strudwick patients.
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Spondyloepimetaphyseal dysplasia (SEMD) Strudwick type is a rare autosomal dominant condition arising from defects in COL2A1 the genes responsible for the biosynthesis of procollagen type II.
    explanation: >-
      Confirms rarity with case-report-level reporting rather than population-based epidemiology.
  - reference: PMID:25604898
    reference_title: "A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The majority of the patients (80/93) had short stature, with radiological features of SEDC (n = 64), others having SEMD (n = 5), Kniest dysplasia (n = 7), spondyloperipheral dysplasia (n = 2), or Torrance-like dysplasia (n = 2).
    explanation: >-
      Largest COL2A1 cohort study confirms SEMD is rare even within the type II collagenopathy spectrum (5 of 93 patients).
pathophysiology:
- name: Collagen Triple Helix Disruption
  description: >
    Glycine-to-amino-acid substitutions in the Gly-X-Y repeats of the COL2A1
    triple-helical domain destabilize the type II collagen triple helix through a
    dominant-negative mechanism. Because glycine is the only amino acid small
    enough to fit in the center of the triple helix, its substitution prevents
    proper chain folding. Even a single mutant alpha-1(II) chain incorporated into
    a trimeric molecule disrupts the entire structure, causing altered
    electrophoretic mobility, reduced thermostability, and slow secretion.
  genes:
  - preferred_term: COL2A1
    term:
      id: hgnc:2200
      label: COL2A1
  molecular_functions:
  - preferred_term: extracellular matrix structural constituent
    term:
      id: GO:0005201
      label: extracellular matrix structural constituent
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: Collagen Fibril Organization
    term:
      id: GO:0030199
      label: collagen fibril organization
  - preferred_term: Collagen Biosynthesis
    term:
      id: GO:0032964
      label: collagen biosynthetic process
  evidence:
  - reference: PMID:7550321
    reference_title: "Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1.
    explanation: >-
      Biochemical characterization in three unrelated SEMD Strudwick patients established that heterozygous COL2A1 mutations produce abnormal alpha-1(II) collagen chains.
  - reference: PMID:12925722
    reference_title: "A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All previously reported autosomal dominant mutations causing SEMD have substituted an obligate glycine within the triple helix, in particular at codons 292, 304 and 709 in the three reported Strudwick-type patients.
    explanation: >-
      Documents that all known SEMD Strudwick mutations substitute glycine residues within the triple helix, confirming the dominant-negative mechanism.
  - reference: PMID:26443184
    reference_title: "Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats of the alpha 1 chain. These mutations disrupt the collagen triple helix and are common in achondrogenesis type II and hypochondrogenesis.
    explanation: >-
      Comprehensive review of 415 COL2A1 mutations confirms that glycine substitutions in the Gly-X-Y repeats produce dominant-negative effects disrupting the triple helix.
- name: ER Retention and Impaired Procollagen Proteostasis
  description: >
    Misfolded type II procollagen molecules accumulate in the endoplasmic
    reticulum of chondrocytes, causing ER distention and an ER storage disorder
    phenotype. The cellular response to this accumulation is variant-dependent:
    some mutations activate canonical ER stress and the unfolded protein response
    (UPR), leading to chondrocyte apoptosis and growth plate disorganization.
    However, recent iPSC-derived cartilage models demonstrate that certain
    COL2A1 substitutions cause ER retention and defective matrix deposition
    without robust UPR activation, indicating a failure in cellular surveillance
    where misfolded procollagen evades ER quality control. Both pathways converge
    on reduced chondrocyte proliferation and compromised cartilage matrix.
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  - preferred_term: Growth Plate Chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  biological_processes:
  - preferred_term: ER Unfolded Protein Response
    term:
      id: GO:0030968
      label: endoplasmic reticulum unfolded protein response
  - preferred_term: Response to ER Stress
    term:
      id: GO:0034976
      label: response to endoplasmic reticulum stress
  - preferred_term: Chondrocyte Differentiation
    term:
      id: GO:0002062
      label: chondrocyte differentiation
  evidence:
  - reference: PMID:25451152
    reference_title: "Mechanisms of aberrant organization of growth plates in conditional transgenic mouse model of spondyloepiphyseal dysplasia associated with the R992C substitution in collagen II."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Our studies demonstrated that chondrocytes expressing the thermolabile R992C mutant collagen II molecules endured endoplasmic reticulum stress, had atypical polarization, and had reduced proliferation.
    explanation: >-
      Conditional transgenic mouse model of SED demonstrates ER stress, atypical chondrocyte polarization, and reduced proliferation as direct consequences of mutant collagen II expression.
  - reference: PMID:25187577
    reference_title: "Modeling type II collagenopathy skeletal dysplasia by directed conversion and induced pluripotent stem cells."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The COL2pathy-iChon cells showed suppressed expression of COL2A1 and significant apoptosis. A distended endoplasmic reticulum (ER) was detected, thus suggesting the adaptation of gene expression and cell death caused by excess ER stress.
    explanation: >-
      Patient-derived iPSC chondrocytes demonstrate ER distension, suppressed COL2A1 expression, and apoptosis, directly modeling the ER stress pathomechanism.
  - reference: PMID:40602718
    reference_title: "Failed cellular surveillance enables pathogenic matrix deposition in a COL2A1-related osteoarthritis."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Arg719Cys procollagen-II was excessively post-translationally modified and partially retained within the endoplasmic reticulum (ER), leading to ER distention. Notably, despite introduction of an aberrant cysteine residue-expected to engage redox-sensitive folding and quality control pathways-Arg719Cys procollagen-II was not detectably recognized by the ER proteostasis network.
    explanation: >-
      Demonstrates that certain COL2A1 substitutions cause ER retention and matrix deficiency without canonical UPR activation, revealing a failed surveillance mechanism.
- name: Disrupted Endochondral Ossification
  description: >
    The combined effects of ER stress-induced chondrocyte dysfunction, reduced
    proliferation, and premature apoptosis in the growth plate disrupt the normal
    sequence of endochondral ossification. Chondrocytes fail to organize into
    proper columns, and the progression from proliferative to hypertrophic zones
    is impaired. The resulting disorganized growth plate architecture underlies
    the characteristic skeletal abnormalities including short-trunk dwarfism,
    platyspondyly, and metaphyseal dysplasia.
  cell_types:
  - preferred_term: Growth Plate Chondrocyte
    term:
      id: CL:1000217
      label: growth plate cartilage chondrocyte
  - preferred_term: Osteoblast
    term:
      id: CL:0000062
      label: osteoblast
  biological_processes:
  - preferred_term: Endochondral Ossification
    term:
      id: GO:0001958
      label: endochondral ossification
  - preferred_term: Cartilage Development
    term:
      id: GO:0051216
      label: cartilage development
  - preferred_term: Bone Development
    term:
      id: GO:0060348
      label: bone development
  evidence:
  - reference: PMID:25451152
    reference_title: "Mechanisms of aberrant organization of growth plates in conditional transgenic mouse model of spondyloepiphyseal dysplasia associated with the R992C substitution in collagen II."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we analyzed the pathomechanisms responsible for growth alterations in transgenic mice with conditional expression of the R992C collagen II mutation. Specifically, we studied the alterations of the growth plates of mutant mice in which chondrocytes lacked their typical columnar arrangement.
    explanation: >-
      Directly demonstrates that mutant collagen II expression disrupts growth plate columnar organization, a hallmark of impaired endochondral ossification.
  - reference: PMID:7550321
    reference_title: "Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Individuals affected with these disorders exhibit abnormalities of the growth plate, nucleus pulposus, and vitreous humor, which are tissues that contain type II collagen.
    explanation: >-
      Growth plate abnormalities in SEMD Strudwick patients confirm disrupted endochondral ossification in human disease.
- name: Defective Articular Cartilage Matrix
  description: >
    Type II collagen is the major structural protein of articular cartilage.
    Mutant collagen molecules that are secreted form abnormal fibrils with
    compromised mechanical properties. Combined with abnormal joint geometry from
    the skeletal dysplasia (coxa vara, genu valgum), this predisposes to
    accelerated cartilage degradation and premature osteoarthritis.
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  biological_processes:
  - preferred_term: Collagen Fibril Organization
    term:
      id: GO:0030199
      label: collagen fibril organization
  evidence:
  - reference: PMID:18328979
    reference_title: "Spondylo-epi-metaphyseal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      epiphyseal dysplasia is often a predominant feature, and the course of the disease is marked by premature osteoarthritis
    explanation: >-
      Review of SEMD disorders confirms premature osteoarthritis as a hallmark complication related to epiphyseal cartilage defects.
  - reference: PMID:12925722
    reference_title: "A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis
    explanation: >-
      Early-onset degenerative osteoarthrosis documented in a three-generation Strudwick family reflects the defective articular cartilage matrix.
genetic:
- name: COL2A1
  association: Causative
  gene_term:
    preferred_term: COL2A1
    term:
      id: hgnc:2200
      label: COL2A1
  notes: >
    Heterozygous missense mutations substituting obligate glycine residues within
    the Gly-X-Y triple-helical repeats. Known Strudwick-type mutations include
    Gly292, Gly304, Gly709, Gly154 (recurrent in Finnish cases), Gly262Asp, and
    Gly283Arg. These are dominant-negative mutations: incorporation of even one
    mutant chain disrupts the entire trimeric collagen molecule.
  features: Glycine substitutions in Gly-X-Y repeats of the triple helical domain
  evidence:
  - reference: PMID:7550321
    reference_title: "Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We now describe the biochemical characterization of defects in alpha 1(II) collagen in three unrelated individuals with SEMD Strudwick, each of which is due to heterozygosity for a unique mutation in COL2A1.
    explanation: >-
      Landmark paper establishing that heterozygous COL2A1 mutations cause SEMD Strudwick through biochemical characterization in three unrelated patients.
  - reference: PMID:12925722
    reference_title: "A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A point mutation within exon 20 of the COL2A1 gene was identified that substituted a glycine for an aspartic acid residue at codon 262.
    explanation: >-
      Identifies a novel Gly262Asp mutation in a three-generation family, extending the mutational spectrum.
  - reference: PMID:26443184
    reference_title: "Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Over 700 patients were recorded, harboring 415 different mutations. One-third of the mutations are dominant-negative mutations that affect the glycine residue in the G-X-Y repeats of the alpha 1 chain.
    explanation: >-
      Comprehensive mutation database review establishes glycine substitutions as the major class of dominant-negative COL2A1 mutations across type II collagenopathies.
  - reference: PMID:17163530
    reference_title: "COL2A1-related skeletal dysplasias with predominant metaphyseal involvement."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One patient who carried a Gly283Arg substitution had a pattern of metaphyseal dysplasia that corresponded precisely to what was termed 'Murdoch type metaphyseal dysplasia' in 1960s and was renamed Strudwick type SEMD in 1980s.
    explanation: >-
      Identifies Gly283Arg as another glycine substitution producing the Strudwick pattern of metaphyseal dysplasia.
phenotypes:
- category: Skeletal
  name: Disproportionate Short-Trunk Short Stature
  description: >
    Short stature with disproportionately short trunk.
    Limbs are shortened but hands and feet are typically average-sized.
  phenotype_term:
    preferred_term: Disproportionate short-trunk short stature
    term:
      id: HP:0003521
      label: Disproportionate short-trunk short stature
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).
    explanation: >-
      Disproportionate short stature is one of the defining features of SEMD Strudwick.
- category: Skeletal
  name: Limb Undergrowth
  description: >
    Limb shortening accompanies the short-trunk dysplasia and is evident in
    detailed Strudwick family and longitudinal case reports.
  phenotype_term:
    preferred_term: Limb undergrowth
    term:
      id: HP:0009826
      label: Limb undergrowth
  evidence:
  - reference: PMID:12925722
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis
    explanation: >-
      Direct Strudwick family report identifies limb shortening as part of the phenotype.
  - reference: PMID:8723096
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skeletal radiographs showed an evolution from short tubular bones, delayed epiphyseal development, and mild vertebral involvement to severe metaphyseal dysplasia with dappling irregularities, and hip "dysplasia."
    explanation: >-
      Longitudinal radiographic follow-up in Gly154Arg SEMD cases, later cited as consistent with the Strudwick subtype, documents appendicular shortening.
- category: Skeletal
  name: Scoliosis
  description: >
    Progressive scoliosis is a major feature requiring monitoring and
    often surgical intervention.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).
    explanation: >-
      Scoliosis is one of the characteristic features of SEMD Strudwick.
- category: Skeletal
  name: Kyphosis
  description: >
    Exaggerated anterior convexity of the thoracic spine that can be severe
    and progressive.
  phenotype_term:
    preferred_term: Kyphosis
    term:
      id: HP:0002808
      label: Kyphosis
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Severe kyphosis documented as an orthopaedic manifestation of SEMD Strudwick.
- category: Skeletal
  name: Hyperlordosis
  description: >
    Excessive forward curvature of the lumbar spine.
  phenotype_term:
    preferred_term: Hyperlordosis
    term:
      id: HP:0003307
      label: Hyperlordosis
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Lordosis of dorsal and lumbar spines documented in SEMD Strudwick patients.
  - reference: PMID:1870932
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis.
    explanation: >-
      Classic radiology case report documents lumbar lordosis from birth.
- category: Skeletal
  name: Pectus Carinatum
  description: >
    Protuberant chest deformity is characteristic.
  phenotype_term:
    preferred_term: Pectus carinatum
    term:
      id: HP:0000768
      label: Pectus carinatum
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).
    explanation: >-
      Pectus carinatum is a characteristic feature of SEMD Strudwick.
- category: Skeletal
  name: Metaphyseal Dysplasia
  description: >
    Characteristic dappled or flocculated metaphyseal changes on radiographs,
    consisting of expanded metaphyses with islands of sclerosis interspersed
    with lucent areas. This is the hallmark radiological feature distinguishing
    SEMD Strudwick from spondyloepiphyseal dysplasia congenita.
  phenotype_term:
    preferred_term: Metaphyseal dysplasia
    term:
      id: HP:0100255
      label: Metaphyseal dysplasia
  phenotype_contexts:
  - onset:
      onset_category: INFANTILE
      notes: The classic Strudwick radiology case reported metaphyseal irregularity developing during infancy.
    evidence:
    - reference: PMID:1870932
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The distinguishing radiologic feature of this condition is the striking irregularity of long bone metaphyses which develops during infancy.
      explanation: >-
        Supports infantile onset of the hallmark metaphyseal irregularity.
  evidence:
  - reference: PMID:7550321
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Strudwick type of spondyloepimetaphyseal dysplasia (SEMD) is characterized by disproportionate short stature, pectus carinatum, and scoliosis, as well as dappled metaphyses (which are not seen in SEDC).
    explanation: >-
      Dappled metaphyses are the key distinguishing feature of SEMD Strudwick versus SEDC.
  - reference: PMID:17163530
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A mild degree of metaphyseal dysplasia can be seen in the so-called Strudwick variant of spondyloepimetaphyseal dysplasia and is generally mild or absent in other forms.
    explanation: >-
      Confirms metaphyseal dysplasia as a defining feature of the Strudwick variant of SEMD.
  - reference: PMID:1870932
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The distinguishing radiologic feature of this condition is the striking irregularity of long bone metaphyses which develops during infancy.
    explanation: >-
      Classic Strudwick case report directly supports infantile onset of the hallmark metaphyseal irregularity.
- category: Skeletal
  name: Delayed Epiphyseal Ossification
  description: >
    Delayed ossification and development of the proximal femoral epiphyses is
    present from birth and persists as part of the evolving radiographic
    phenotype.
  phenotype_term:
    preferred_term: Delayed epiphyseal ossification
    term:
      id: HP:0002663
      label: Delayed epiphyseal ossification
  phenotype_contexts:
  - onset:
      onset_category: CONGENITAL
      notes: Delayed proximal femoral epiphyseal ossification was present at birth in the classic Strudwick radiology case.
    evidence:
    - reference: PMID:1870932
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis.
      explanation: >-
        Supports congenital onset of delayed proximal femoral epiphyseal ossification.
  evidence:
  - reference: PMID:1870932
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis.
    explanation: >-
      Direct Strudwick case report documents delayed ossification of the proximal femoral epiphyses at birth.
  - reference: PMID:8723096
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The skeletal radiographs showed an evolution from short tubular bones, delayed epiphyseal development, and mild vertebral involvement to severe metaphyseal dysplasia with dappling irregularities, and hip "dysplasia."
    explanation: >-
      Longitudinal Gly154Arg SEMD cases document delayed epiphyseal development during follow-up.
- category: Skeletal
  name: Coxa Vara
  description: >
    Decreased femoral neck-shaft angle, contributing to gait abnormalities
    and hip joint dysfunction.
  phenotype_term:
    preferred_term: Coxa vara
    term:
      id: HP:0002812
      label: Coxa vara
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Coxa vara documented as an orthopaedic manifestation in SEMD Strudwick.
  - reference: PMID:1870932
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis.
    explanation: >-
      Classic radiology case documents coxa vara in congenital Strudwick presentation.
- category: Skeletal
  name: Genu Valgum
  description: >
    Knock-knees may develop with growth due to metaphyseal and epiphyseal
    irregularities of the distal femur and proximal tibia.
  phenotype_term:
    preferred_term: Genu valgum
    term:
      id: HP:0002857
      label: Genu valgum
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Genu valgum documented as a lower limb malalignment manifestation in SEMD Strudwick.
- category: Skeletal
  name: Atlantoaxial Instability
  description: >
    Pathological movement at the C1-C2 junction, often associated with
    hypoplasia of the odontoid process. This represents a potentially
    life-threatening complication requiring neurosurgical surveillance.
  phenotype_term:
    preferred_term: Atlantoaxial instability
    term:
      id: HP:0003467
      label: Atlantoaxial instability
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Atlantoaxial instability with hypoplastic odontoid peg documented in SEMD Strudwick patients.
- category: Skeletal
  name: Hypoplasia of the Odontoid Process
  description: >
    Underdevelopment of the dens of the axis vertebra, predisposing to
    atlantoaxial instability and risk of spinal cord compression.
  phenotype_term:
    preferred_term: Hypoplasia of the odontoid process
    term:
      id: HP:0003311
      label: Hypoplasia of the odontoid process
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Hypoplastic odontoid peg documented as an orthopaedic manifestation in SEMD Strudwick.
  - reference: PMID:1870932
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features in common include delayed ossification of the public bones and proximal femoral epiphyses, coxa vara, odontoid hypoplasia and lumbar lordosis.
    explanation: >-
      Classic Strudwick case report documents odontoid hypoplasia at birth.
- category: Ophthalmologic
  name: Myopia
  description: >
    Myopia, often high-grade, occurs as a consequence of abnormal type II
    collagen in the developing eye. Type II collagen is a major structural
    component of the vitreous humor.
  phenotype_term:
    preferred_term: Myopia
    term:
      id: HP:0000545
      label: Myopia
  evidence:
  - reference: PMID:12925722
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis
    explanation: >-
      Myopia documented as a specific phenotypical feature in a three-generation family.
  - reference: PMID:25383842
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He was highly myopic and had a visual acuity of 20/80 in the right eye and counting fingers in the left eye.
    explanation: >-
      Direct Strudwick retinal case report shows that the myopia can be high-grade.
- category: Ophthalmologic
  name: Retinal Detachment
  description: >
    Retinal detachment can occur due to abnormal vitreous structure and
    traction on the retina from defective type II collagen fibrils in the
    vitreous humor.
  phenotype_term:
    preferred_term: Retinal detachment
    term:
      id: HP:0000541
      label: Retinal detachment
  evidence:
  - reference: PMID:25383842
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A 13-year-old patient diagnosed with spondyloepimetaphyseal dysplasia-Strudwick type presented with a localized superior temporal retinal detachment in the right eye and a 180° giant retinal tear with an associated macula-off retinal detachment in the left eye.
    explanation: >-
      Direct Strudwick case report documents bilateral rhegmatogenous retinal detachment in adolescence.
- category: Musculoskeletal
  name: Early-Onset Osteoarthritis
  description: >
    Premature degenerative osteoarthritis is a significant complication,
    particularly affecting the hips. Results from both defective articular
    cartilage matrix and abnormal joint geometry.
  phenotype_term:
    preferred_term: Osteoarthritis
    term:
      id: HP:0002758
      label: Osteoarthritis
  evidence:
  - reference: PMID:12925722
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the autosomal dominant Strudwick-type SEMD in a three-generation family, showing specific phenotypical features such as chest deformity, limb shortening, myopia and early-onset degenerative osteoarthrosis
    explanation: >-
      Early-onset degenerative osteoarthrosis documented as a specific phenotypical feature.
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Early severe hip osteoarthritis documented with 30-year follow-up.
- category: Skeletal
  name: Hip Subluxation
  description: >
    Subluxation of the hip joint due to epiphyseal dysplasia and
    abnormal acetabular development.
  phenotype_term:
    preferred_term: Hip subluxation
    term:
      id: HP:0030043
      label: Hip subluxation
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Hip subluxation documented as an orthopaedic manifestation in SEMD Strudwick.
- category: Skeletal
  name: Talipes Equinovarus
  description: >
    Clubfoot deformity may occur as part of the lower limb malalignment
    spectrum in SEMD Strudwick.
  phenotype_term:
    preferred_term: Talipes equinovarus
    term:
      id: HP:0001762
      label: Talipes equinovarus
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The orthopaedic manifestations of patients can be hypoplastic odontoid peg with atlantoaxial instability, severe kyphosis or lordosis of dorsal and lumbar spines, hip subluxation, coxa vara and early severe hip osteoarthritis, and malalignment of lower limbs like genu valgum or club foot.
    explanation: >-
      Club foot documented as a lower limb malalignment manifestation in SEMD Strudwick.
animal_models:
- species: Mouse
  genotype: Col2a1 R992C conditional transgenic
  description: >
    Conditional transgenic mice expressing the R992C collagen II mutation in
    chondrocytes develop disorganized growth plates with loss of columnar
    chondrocyte arrangement, ER stress, aberrant cell polarization, reduced
    proliferation, and abnormal primary cilia morphology. Switching off transgene
    expression restores normal growth plate morphology, confirming direct causality.
  evidence:
  - reference: PMID:25451152
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      chondrocytes expressing the thermolabile R992C mutant collagen II molecules endured endoplasmic reticulum stress, had atypical polarization, and had reduced proliferation. Moreover, we demonstrated aberrant organization and morphology of primary cilia.
    explanation: >-
      R992C mouse model recapitulates key aspects of type II collagenopathy pathomechanism including ER stress and growth plate disorganization.
experimental_models:
- name: COL2A1 patient-derived iPSC chondrocytes
  description: >
    Fibroblasts from type II collagenopathy patients were directly converted
    to induced chondrogenic (iChon) cells and also reprogrammed to iPSCs then
    differentiated to chondrocytes. Both systems showed distended ER, suppressed
    COL2A1 expression, and significant apoptosis. Chemical chaperone treatment
    partially rescued apoptosis and increased collagen secretion, providing a
    drug screening platform.
  experimental_model_type: IPSC_DERIVED_MODEL
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  publication: PMID:25187577
- name: Isogenic COL2A1 Arg719Cys iPSC-derived cartilage
  description: >
    Isogenic iPSC lines carrying the Arg719Cys COL2A1 substitution were
    differentiated into chondrocytes and cartilage tissues. Mutant tissues
    displayed a deficient collagen-II matrix, ER distention with intracellular
    procollagen retention, and excessive post-translational modification. The
    mutant procollagen was not recognized by the ER proteostasis network and
    the unfolded protein response was not activated, demonstrating a failure
    in cellular surveillance that allows secretion of defective collagen and
    pathogenic matrix deposition.
  experimental_model_type: IPSC_DERIVED_MODEL
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: Chondrocyte
    term:
      id: CL:0000138
      label: chondrocyte
  publication: PMID:40602718
diagnosis:
- name: Clinical, Radiographic, and Molecular Diagnosis
  description: >-
    SEMD Strudwick type is diagnosed from spondyloepimetaphyseal radiographic
    features — notably the characteristic "dappled" (mottled) metaphyseal
    changes that distinguish it from SEDC — and confirmed as a COL2A1-related
    type II collagen disorder by molecular genetic testing. Differential
    diagnosis includes SEDC, Kniest dysplasia, spondyloperipheral dysplasia,
    and other type II collagenopathies, which can overlap at birth.
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: MAXO:0000533
      label: molecular genetic testing
  evidence:
  - reference: PMID:31021589
    reference_title: "Type II Collagen Disorders Overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Provide an evaluation strategy to identify the genetic cause of a type II collagen disorder in a proband"
    explanation: >-
      GeneReviews provides the evaluation strategy for identifying the COL2A1
      cause within the type II collagen disorder spectrum that includes SEMD
      Strudwick type.
  - reference: PMID:31021589
    reference_title: "Type II Collagen Disorders Overview."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Review the differential diagnosis of type II collagen disorders with a focus on genetic conditions"
    explanation: >-
      Supports differential diagnosis of Strudwick type against SEDC and other
      type II collagenopathies.
treatments:
- name: Orthopedic Surveillance and Surgery
  description: >
    Management of progressive scoliosis and kyphosis (bracing, spinal fusion
    when severe), correction of limb deformities (osteotomy for coxa vara
    and genu valgum), hip arthroplasty for severe osteoarthritis, and
    monitoring for atlantoaxial instability with surgical stabilization
    if needed.
  treatment_term:
    preferred_term: Orthopedic surgery
    term:
      id: MAXO:0000004
      label: surgical procedure
  evidence:
  - reference: PMID:16280719
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a mother and daughter with SEMD Strudwick Type and describe their orthopaedic problems, surgical management and clinical outcome after 30 years and 7 years of follow-up respectively.
    explanation: >-
      Long-term follow-up documents the orthopedic surgical interventions required in SEMD Strudwick patients.
  - reference: PMID:25604898
    reference_title: "A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Over 50% of the patients had undergone orthopedic surgery, usually for scoliosis, femoral osteotomy or hip replacement.
    explanation: >-
      Large cohort demonstrates that over half of COL2A1 patients require orthopedic surgery.
- name: Ophthalmologic Surveillance
  description: >
    Regular ophthalmologic evaluation for myopia progression and retinal
    detachment screening. Type II collagen abnormalities in the vitreous
    create ongoing risk for retinal complications.
- name: Physical Therapy and Orthotic Devices
  description: >
    Rehabilitation and orthotic support to manage mobility limitations
    and prevent progressive deformity.
  treatment_term:
    preferred_term: Orthotic device usage
    term:
      id: MAXO:0000482
      label: orthotic device usage
- name: Pulmonary Monitoring
  description: >
    Monitoring for restrictive lung disease secondary to severe
    kyphoscoliosis. Non-invasive ventilation support may be required
    when respiratory compromise develops.
datasets:
references:
- reference: PMID:31021589
  title: "Type II Collagen Disorders Overview."
  tags:
  - GeneReviews
  findings: []
📚

References & Deep Research

References

1
PMID:31021589
Type II Collagen Disorders Overview.
No top-level findings curated for this source.

Deep Research

3
Disorder ▸

Disorder

  • Name: Spondyloepimetaphyseal Dysplasia Strudwick Type
  • Category: Mendelian
  • Existing deep-research providers: cyberian-codex, perplexity
  • Existing evidence reference count in YAML: 21

Key Pathophysiology Nodes

  • Type II Collagen Dysfunction
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1002/dvdy.24131
  • DOI:10.1002/dvdy.24463
  • DOI:10.1002/humu.22915
  • DOI:10.1002/humu.9497
  • DOI:10.1073/pnas.0407510102
  • DOI:10.1073/pnas.0608449104
  • DOI:10.1073/pnas.89.10.4583
  • PMID:10591625
  • PMID:12713737
  • PMID:12925722
  • PMID:17163530
  • PMID:18328979
  • PMID:20513134
  • PMID:6365388
  • PMID:7550321
Falcon ▸
Disease Pathophysiology Research Template
Edison Scientific Literature 26 citations 2026-04-02T15:58:09.841399

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Pathophysiology Research Template

Target Disease

  • Disease Name: Spondyloepimetaphyseal Dysplasia Strudwick Type
  • MONDO ID: (if available)
  • Category: Mendelian

Research Objectives

Please provide a comprehensive research report on the pathophysiology of Spondyloepimetaphyseal Dysplasia Strudwick Type. Focus on the molecular and cellular mechanisms underlying disease progression.

Required Information

1. Core Pathophysiology

  • What are the primary pathophysiological mechanisms?
  • What molecular pathways are dysregulated?
  • What cellular processes are affected?

2. Key Molecular Players

  • Genes/Proteins: Which genes are causally involved or implicated?
  • Chemical Entities: What metabolites, drugs, or small molecules are relevant?
  • Cell Types: Which cell types are primarily affected?
  • Anatomical Locations: Which tissues/organs are involved?

3. Biological Processes (for GO annotation)

  • What biological processes (GO terms) are disrupted?
  • Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

4. Cellular Components

  • Where in the cell do key processes occur?
  • Consider: organelles, membrane compartments, extracellular space, etc.

5. Disease Progression

  • What is the sequence of events from initial trigger to clinical manifestation?
  • Are there distinct stages or phases?

6. Phenotypic Manifestations

  • What are the key clinical phenotypes?
  • How do they relate to the underlying mechanisms?

Citation Requirements

  • Cite primary literature (PMID preferred) for all mechanistic claims
  • Prioritize recent reviews and landmark papers
  • Include direct quotes where possible to support key statements

Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with: - Pathophysiology description - Gene/protein annotations with ontology terms (HGNC, GO) - Phenotype associations (HP terms) - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Evidence items with PMIDs

Disease Pathophysiology Research Report: Spondyloepimetaphyseal Dysplasia, Strudwick Type (SEMD-ST)

Executive summary

Spondyloepimetaphyseal dysplasia, Strudwick type (SEMD-ST) is an autosomal dominant type II collagenopathy caused by pathogenic variants in COL2A1, the gene encoding the α1(II) chain of type II collagen, the major fibrillar collagen of hyaline cartilage. The dominant disease mechanism is typically dominant-negative disruption of procollagen-II folding/assembly (especially triple-helix glycine substitutions), resulting in defective cartilage extracellular matrix (ECM) and abnormal endochondral ossification. A central cellular pathology is impaired ER proteostasis in chondrocytes (ER retention/storage of mutant procollagen-II), which in some contexts activates ER stress/UPR and apoptosis, while recent 2024 human iPSC-derived cartilage models show that certain disease-causing COL2A1 substitutions can cause ER retention and matrix defects without a robust canonical unfolded protein response (UPR), implying variant-specific “failed surveillance” mechanisms that still culminate in defective ECM deposition. (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9, yammine2023erprocollagenstorage pages 1-5, yammine2024humancartilagemodel pages 4-7)

1) Key concepts and definitions (current understanding)

1.1 Disease definition and identifiers

  • Disease name: Spondyloepimetaphyseal dysplasia, Strudwick type (SEMD-ST).
  • OMIM: 184250 (explicitly linked to SEMD Strudwick/type II collagenopathy and COL2A1 in comparative type II collagenopathy discussions). (machol2017cornerfracturetype pages 4-5)
  • Inheritance: Autosomal dominant. (machol2017cornerfracturetype pages 4-5)
  • MONDO / Orphanet: Not captured in the retrieved full-text evidence set; therefore not reported here.

1.2 How SEMD-ST fits within type II collagenopathies

  • SEMD is described as essentially spondyloepiphyseal dysplasia (SED) with marked metaphyseal changes; metaphyseal abnormalities of long tubular bones become more evident with age. (morales2025theuseof pages 42-47)
  • SEMD Strudwick is placed within the SEDC radiologic family (type II collagenopathy group) in radiology-focused classification: shared features include delayed ossification of juxtatruncal bones, vertebral abnormalities (e.g., pear-shaped vertebrae from characteristic contouring), and predominant short-trunk/short-neck short stature. (handa2021radiologicfeaturesof pages 2-3)

1.3 Core mechanistic concept: “Type II collagenopathy”

  • Type II collagen (COL2A1 product) is a major structural component of hyaline cartilage ECM and is also relevant to vitreous and inner ear, consistent with extraskeletal ocular/auditory features observed across COL2A1 disorders. (nenna2019col2a1genemutations pages 2-3, handa2021radiologicfeaturesof pages 2-3)

2) Core pathophysiology (molecular and cellular mechanisms)

2.1 Primary molecular mechanisms

Mechanistically, COL2A1 disease can be conceptualized as two broad classes: 1. Dominant-negative structural variants (especially missense in the triple helix; glycine substitutions in the Gly-X-Y repeat) that produce abnormal procollagen-II that misfolds/assembles poorly and disrupts ECM. (nenna2019col2a1genemutations pages 2-3, aljuid2026col2a1mutationsand pages 7-8, morales2025theuseof pages 42-47) 2. Haploinsufficiency due to nonsense/frameshift/splice variants that trigger nonsense-mediated decay (NMD), lowering collagen II quantity and tending toward milder phenotypes within the COL2A1 spectrum. (nenna2019col2a1genemutations pages 2-3, aljuid2026col2a1mutationsand pages 7-8)

In SEMD-ST specifically, the molecular mechanism is generally described as dominant-negative COL2A1 mutations, often glycine substitutions. (morales2025theuseof pages 42-47)

2.2 Procollagen-II biosynthesis, folding, and ER proteostasis (central cellular hub)

A defining mechanistic hub is the endoplasmic reticulum (ER) of chondrocytes, where procollagen folds, undergoes post-translational modification, and is trafficked for secretion.

Recent 2024 mechanistic developments (human iPSC-derived cartilage models) - In a COL2A1 Gly1170Ser model, procollagen-II is slow to fold and secrete, accumulates intracellularly with an ER storage disorder phenotype, yet intracellular accumulation is not recognized by the UPR (uncoupled from canonical UPR activation). (yammine2023erprocollagenstorage pages 1-5) - Deeper mechanistic profiling in that model indicates mutant procollagen-II can become hypermodified, accumulate in a dilated ER, and still fail to mount a substantive UPR (e.g., BiP interaction not increased; RNA-seq lacking UPR activation), suggesting collagen triple-helix features may evade BiP-based sensing. (yammine2023erprocollagenstorage pages 15-18) - In a second 2024 iPSC-derived cartilage model (COL2A1 Arg719Cys), cartilage matrix is deposited but the collagen-II network is sparse/deficient and ER is distended, consistent with a storage defect; transcriptional matrisome changes are minimal, supporting a mechanism dominated by protein-level folding/assembly defects rather than broad gene-expression remodeling. (yammine2024humancartilagemodel pages 4-7, yammine2024humancartilagemodel pages 1-4) - That Arg719Cys model additionally supports a “failed surveillance” mechanism: the ER proteostasis network does not differentially engage the defective procollagen-II, implying defective collagen can evade quality-control recognition and still be secreted/accumulated, producing a defective ECM. (yammine2024humancartilagemodel pages 4-7, yammine2024humancartilagemodel pages 1-4)

Canonical (review-synthesized) ER stress/UPR-to-apoptosis model - In broader COL2A1/type II collagenopathy literature syntheses, intracellular retention of misfolded collagen can activate ER stress and UPR (PERK/ATF6/IRE1 branches), with downstream factors (ATF4, spliced XBP1) and if unresolved, induction of CHOP/caspases and chondrocyte apoptosis, disrupting growth-plate organization. (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9)

Taken together, current understanding supports variant- and context-dependent ER stress biology: some COL2A1 variants may drive overt UPR/apoptosis, while others cause clinically meaningful ER storage and ECM insufficiency with minimal canonical UPR, implying additional non-canonical proteostasis failure modes. (yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4)

2.3 ECM assembly defects and downstream tissue dysfunction

  • Molecular/cellular defects in procollagen folding/secretion produce reduced extracellular collagen-II deposition and abnormal/sparse collagen fibrils, leading to defective cartilage mechanical properties and disrupted cartilage–bone coupling during endochondral ossification. (nenna2019col2a1genemutations pages 2-3, yammine2024humancartilagemodel pages 4-7)
  • Growth plate architecture changes (including abnormal organization/proliferation in collagenopathy models) link molecular defects to impaired endochondral ossification and skeletal dysplasia phenotypes. (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9)

3) Key molecular players

3.1 Genes/Proteins (causal and mechanistically implicated)

  • COL2A1 (HGNC:2200): causal gene for SEMD-ST/type II collagenopathy. (machol2017cornerfracturetype pages 4-5, morales2025theuseof pages 42-47)
  • ER stress/proteostasis signaling modules (mechanistic axis in collagenopathies): PERK/EIF2AK3, ATF6, IRE1/ERN1, XBP1, CHOP/DDIT3, and chaperone engagement (e.g., BiP/HSPA5 discussed as a key UPR sensor with limited differential engagement in specific collagen-II storage phenotypes). (aljuid2026col2a1mutationsand pages 7-8, yammine2023erprocollagenstorage pages 15-18)

3.2 Chemical entities / small molecules

  • The most “relevant chemical entities” in the mechanistic evidence are amino acids defining pathogenic substitutions (e.g., glycine substitutions in Gly-X-Y and Arg→Cys substitutions), which are directly linked to folding and matrix phenotypes. (nenna2019col2a1genemutations pages 2-3, yammine2024humancartilagemodel pages 4-7)
  • No disease-modifying drugs specific to SEMD-ST were identified in the retrieved mechanistic evidence set.

3.3 Cell types primarily affected

  • Chondrocytes (cartilage-producing cells) are the central affected cell type because they synthesize procollagen-II and maintain cartilage ECM. (nenna2019col2a1genemutations pages 2-3, handa2021radiologicfeaturesof pages 2-3)
  • Growth plate chondrocytes (conceptually) are implicated in abnormal endochondral ossification and short stature; growth-plate disorganization is a recurring downstream theme in collagenopathy models. (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9)

3.4 Anatomical locations (tissues/organs)

  • Hyaline cartilage (including growth plate and articular cartilage) is the primary tissue impacted. (nenna2019col2a1genemutations pages 2-3, handa2021radiologicfeaturesof pages 2-3)
  • Spine/vertebral bodies: platyspondyly and related vertebral anomalies contribute to short trunk phenotype. (handa2021radiologicfeaturesof pages 2-3)
  • Proximal femoral epiphysis/hip region: epiphyseal and hip deformities are common in COL2A1 dysplasia cohorts. (yeter2025diagnosticchallengeof pages 5-12)
  • Cervical spine/odontoid process: odontoid hypoplasia and risk of atlanto-axial instability/spinal cord compression are emphasized. (morales2025theuseof pages 38-42, morales2025theuseof pages 42-47)
  • Extraskeletal: eye (vitreous/retina) and inner ear, consistent with myopia/retinal detachment and hearing loss in COL2A1 disorders. (handa2021radiologicfeaturesof pages 2-3, terhal2015astudyof pages 3-4)

4) Biological processes disrupted (GO-oriented)

A practical GO-oriented set of disrupted processes supported by the evidence includes: - Collagen fibril organization / extracellular matrix organization (defective collagen-II network deposition, sparse fibrils). (nenna2019col2a1genemutations pages 2-3, yammine2024humancartilagemodel pages 4-7) - Protein folding and secretion (slow folding, slow secretion, hypermodification, ER retention). (yammine2023erprocollagenstorage pages 1-5, yammine2023erprocollagenstorage pages 15-18) - Endoplasmic reticulum stress / unfolded protein response (UPR) (context-dependent engagement; canonical PERK/ATF6/IRE1 axis in reviews; UPR uncoupling in 2024 iPSC models). (aljuid2026col2a1mutationsand pages 7-8, yammine2023erprocollagenstorage pages 15-18) - Chondrocyte differentiation / cartilage development / endochondral ossification (growth plate architectural disruption and skeletal dysplasia outcomes). (aljuid2026col2a1mutationsand pages 7-8, handa2021radiologicfeaturesof pages 2-3)

5) Cellular components involved

Key cellular locales (ontology-ready) are: - Rough endoplasmic reticulum (ER): site of procollagen folding and the location of ER storage/retention phenotypes with distended ER cisternae. (yammine2023erprocollagenstorage pages 1-5, yammine2024humancartilagemodel pages 1-4) - Extracellular matrix (collagen-containing ECM): defective collagen-II fibril networks and sparse matrices. (yammine2024humancartilagemodel pages 4-7)

6) Disease progression model (trigger → cellular pathology → clinical manifestation)

A synthesis consistent with the evidence: 1. Trigger: Heterozygous pathogenic COL2A1 variant (often triple-helix glycine substitution; sometimes other substitutions such as Arg→Cys). (nenna2019col2a1genemutations pages 2-3, yammine2024humancartilagemodel pages 4-7) 2. Early molecular effects: Slow folding/assembly of procollagen-II, excessive post-translational modification, reduced secretion, and partial intracellular retention (ER storage). (yammine2023erprocollagenstorage pages 1-5, yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4) 3. Cellular stress and quality-control outcomes: - Some variants/models: ER retention elicits canonical ER stress/UPR signaling and can lead to apoptosis if unresolved. (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9) - Other variants/models (2024): ER retention/storage and matrix failure can occur without robust UPR activation, suggesting “surveillance failure” in ER proteostasis. (yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4) 4. Tissue-level effects: Deficient collagen-II ECM (sparse fibrils) compromises cartilage structure and growth plate organization, impairing endochondral ossification. (yammine2024humancartilagemodel pages 4-7, aljuid2026col2a1mutationsand pages 7-8) 5. Clinical evolution: Infancy resembles SEDC; with age, metaphyseal abnormalities become increasingly evident; spine/hip deformities and cervical instability risks become key management concerns. (morales2025theuseof pages 42-47, morales2025theuseof pages 38-42)

7) Phenotypic manifestations and mechanism links

7.1 Core skeletal phenotypes

  • SEMD Strudwick is characterized as SED-like with marked metaphyseal abnormalities emerging with age. (morales2025theuseof pages 42-47)
  • Radiologic family features include spine/pelvis/proximal epiphysis ossification delay and vertebral abnormalities contributing to short trunk/neck short stature. (handa2021radiologicfeaturesof pages 2-3)
  • Cervical involvement: odontoid hypoplasia/non-fusion → risk of cervical instability and spinal cord compression. (morales2025theuseof pages 38-42, morales2025theuseof pages 42-47)

7.2 Extraskeletal phenotypes

  • Ocular: vitreoretinal degeneration with severe myopia and retinal detachment occurs across type II collagenopathies; in a COL2A1 cohort, myopia and retinal detachment frequencies were quantified (see statistics below). (handa2021radiologicfeaturesof pages 2-3, terhal2015astudyof pages 3-4)
  • Hearing: sensorineural/mixed hearing loss is part of the spectrum; quantified in cohort statistics below. (handa2021radiologicfeaturesof pages 2-3, terhal2015astudyof pages 3-4)

Mechanistic mapping: these reflect tissue distribution of type II collagen beyond growth plate cartilage. (handa2021radiologicfeaturesof pages 2-3)

8) Relevant statistics and data (cohorts; recent where available)

Although SEMD-ST itself is rare and often embedded within broader COL2A1 phenotype cohorts, multiple quantitative observations relevant to SEMD/ST biology are available.

8.1 COL2A1 cohort including SEMD cases (Terhal et al., 2015)

Study: “A study of the clinical and radiological features in a cohort of 93 patients with a COL2A1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype” (publication date: March 2015; URL: https://doi.org/10.1002/ajmg.a.36922). (terhal2015astudyof pages 4-6) Key quantitative findings in the available excerpts: - 93 patients; median age 17 (range 4 months–70 years). (terhal2015astudyof pages 4-6) - Variant class: 68/93 (73%) had missense glycine substitutions in the triple helix. (terhal2015astudyof pages 4-6) - De novo variants: 47/93 (51%); inherited: 31/93 (33%). (terhal2015astudyof pages 4-6) - SEMD present in this broader cohort: SEMD (n = 5). (terhal2015astudyof pages 3-4) - Cervical spine: odontoid hypoplasia 56%; atlanto-axial instability in 5/18 (28%) among those with flexion–extension films. (terhal2015astudyof pages 3-4) - Ocular: myopia 45%; retinal detachment 12% (median age 14 years). (terhal2015astudyof pages 3-4) - Hearing loss: 37%. (terhal2015astudyof pages 3-4)

Terhal et al. also include multiple figures/tables (retrieved as cropped images) summarizing genotype groupings and phenotype correlations (e.g., ocular features and dens hypoplasia correlations). (terhal2015astudyof media 7e789bd0, terhal2015astudyof media 98be3c29)

8.2 Epidemiology statistic (from a concise review)

A concise clinical genetics review reports that spondyloepiphyseal dysplasia congenita (SEDC) is rare with an estimate of ~3.4/1,000,000 and describes frequent ocular/hearing involvement across COL2A1 disorders. (nenna2019col2a1genemutations pages 2-3)

9) Current applications and real-world implementations

9.1 Clinical implementation: surveillance and multidisciplinary care

Because SEMD-ST features include cervical spine risk (odontoid hypoplasia and instability) and frequent ocular/auditory complications across COL2A1 disorders, real-world management commonly includes orthopedic/spine monitoring and ophthalmology/audiology surveillance. Evidence of the prevalence of these complications in a large COL2A1 cohort supports this approach (e.g., quantified odontoid hypoplasia, retinal detachment, and hearing loss). (terhal2015astudyof pages 3-4)

9.2 Diagnostic implementation: phenotype-driven molecular testing

Radiology-driven pattern recognition is emphasized as a way to classify a case into the SEDC/type II collagenopathy family and direct targeted genetic testing (COL2A1). (handa2021radiologicfeaturesof pages 2-3)

9.3 Research implementation (2023–2024): human iPSC-derived cartilage disease models

A major recent development is the use of isogenic iPSC-derived chondrocytes/cartilage to model COL2A1 disease mechanisms in a human context. - These models enable high-resolution mechanistic studies (folding kinetics, proteostasis engagement, ER morphology) and can function as platforms for therapeutic strategy testing targeting ER proteostasis. (yammine2023erprocollagenstorage pages 1-5, yammine2023erprocollagenstorage pages 15-18)

10) Expert opinions / analysis (authoritative source perspectives)

  • Radiology experts emphasize that accurate pattern recognition and family-based classification in collagenopathies is clinically actionable, because it guides appropriate genetic testing and informs anticipation of extraskeletal features (ocular/hearing). (handa2021radiologicfeaturesof pages 2-3)
  • Mechanistic 2024 iPSC-derived cartilage studies provide an expert-driven reinterpretation of collagenopathy cell biology: ER retention of mutant procollagen-II may not necessarily trigger canonical UPR, reframing the assumption that ER storage equals UPR activation in all collagenopathies and highlighting “failed surveillance” as a plausible pathophysiologic theme. (yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4)

Ontology-ready annotations (GO/CL/UBERON/HP/CHEBI-style)

The table below is structured to support direct knowledge-base ingestion.

Category Gene/Protein Pathway/Process (GO) Cellular component Cell type (CL) Anatomy (UBERON) Phenotype (HP) Chemical entity (CHEBI/other) Notes/evidence
Gene/Protein COL2A1 (HGNC:2200); type II collagen alpha-1 chain / collagen II collagen trimerization; extracellular matrix organization; collagen fibril organization rough endoplasmic reticulum; extracellular matrix; collagen-containing extracellular matrix chondrocyte (CL:0000138) hyaline cartilage; growth plate cartilage; vertebral body; femoral epiphysis short stature; platyspondyly; metaphyseal irregularity procollagen II Causal gene for SEMD Strudwick/type II collagenopathy; dominant-negative missense variants, especially glycine substitutions in the triple helix, are typical; reduced matrix deposition and abnormal fibrils are recurrent themes (nenna2019col2a1genemutations pages 2-3, aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9, morales2025theuseof pages 42-47)
Pathway/Process (GO) mutant procollagen II protein folding; protein secretion; endoplasmic reticulum unfolded protein response endoplasmic reticulum lumen; rough ER chondrocyte (CL:0000138) growth plate; articular cartilage skeletal dysplasia progression N/A Mutant procollagen-II folds and secretes slowly, with intracellular retention/ER storage; some COL2A1 variants activate ER stress/UPR, while some recent human cartilage models show ER retention without robust canonical UPR activation (aljuid2026col2a1mutationsand pages 7-8, yammine2023erprocollagenstorage pages 1-5, yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4)
Pathway/Process (GO) EIF2AK3/PERK, ATF6, ERN1/IRE1, XBP1, DDIT3/CHOP response to endoplasmic reticulum stress; unfolded protein response; regulation of apoptotic process ER membrane; nucleus chondrocyte (CL:0000138); growth plate chondrocyte growth plate cartilage impaired endochondral ossification ATF4; sXBP1 Review-level synthesis of COL2A1 collagenopathy mechanisms identifies PERK/ATF6/IRE1 branch signaling, induction of ATF4/sXBP1 and CHOP-mediated toxicity/apoptosis when proteostasis fails (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9)
Pathway/Process (GO) collagen II network; fibrillar matrix partners extracellular matrix assembly; collagen fibril organization; cartilage development extracellular region; collagen-containing extracellular matrix chondrocyte (CL:0000138) hyaline cartilage; articular cartilage; growth plate metaphyseal changes; epiphyseal abnormalities; early degenerative joint disease N/A Slowed folding/hypermodification impairs fibrillogenesis and yields sparse/defective collagen-II matrix; ultrastructural matrix deficiency was demonstrated in recent iPSC-derived human cartilage models (yammine2024humancartilagemodel pages 4-7, yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4)
Cellular component retained procollagen-II intracellular protein transport; ER retention rough endoplasmic reticulum; ER cisterna/lumen chondrocyte (CL:0000138) growth plate cartilage growth plate disorganization N/A Expanded/distended rough ER with retained mutant collagen is a recurring lesion in COL2A1 disease models and reviews, consistent with an ER storage disorder (aljuid2026col2a1mutationsand pages 7-8, yammine2023erprocollagenstorage pages 1-5, yammine2024humancartilagemodel pages 1-4)
Cell type (CL) chondrocyte secretory machinery cartilage development; extracellular matrix secretion rough ER; Golgi-associated secretory pathway; extracellular matrix chondrocyte (CL:0000138) hyaline cartilage; articular cartilage short-trunk short stature; joint disease N/A Chondrocytes are the principal disease cell type because type II collagen is the major matrix component of cartilage; impaired secretion perturbs cartilage architecture and biomechanics (nenna2019col2a1genemutations pages 2-3, aljuid2026col2a1mutationsand pages 6-7, handa2021radiologicfeaturesof pages 2-3)
Cell type (CL) growth plate chondrocyte chondrocyte proliferation; chondrocyte differentiation; endochondral bone morphogenesis growth plate extracellular matrix; ER growth plate chondrocyte epiphyseal growth plate short stature; delayed/abnormal ossification N/A Growth plate chondrocytes show reduced proliferation, abnormal columnar organization, and disturbed differentiation in collagen II dysplasia models, linking molecular defects to impaired linear growth (aljuid2026col2a1mutationsand pages 7-8, aljuid2026col2a1mutationsand pages 8-9)
Anatomy (UBERON) collagen II-rich matrix cartilage development extracellular matrix chondrocyte (CL:0000138) hyaline cartilage (UBERON:0002811) metaphyseal/epiphyseal dysplasia N/A Hyaline cartilage is a core affected tissue because COL2A1 encodes its principal fibrillar collagen; disruption here underlies skeletal deformity (nenna2019col2a1genemutations pages 2-3, handa2021radiologicfeaturesof pages 2-3)
Anatomy (UBERON) vertebral cartilage/bone growth units endochondral ossification growth plate/ECM growth plate chondrocyte vertebral body platyspondyly N/A SEMD Strudwick belongs to the SEDC radiologic family with vertebral abnormalities/pear-shaped or flattened vertebrae and short trunk due to spinal involvement (morales2025theuseof pages 38-42, handa2021radiologicfeaturesof pages 2-3)
Anatomy (UBERON) proximal femoral epiphyseal cartilage endochondral ossification extracellular matrix growth plate chondrocyte femoral epiphysis absent/delayed femoral epiphyseal ossification; coxa vara/valga N/A Capital femoral epiphysis abnormalities and coxa changes are repeatedly reported in COL2A1-related SEDC/SEMD cohorts and case series (yeter2025diagnosticchallengeof pages 5-12, terhal2015astudyof pages 3-4)
Anatomy (UBERON) odontoid process/C2 region skeletal system development cartilage/bone interface chondrocyte lineage cells odontoid process; cervical spine odontoid hypoplasia; atlantoaxial instability; spinal cord compression risk N/A Cervical spine involvement is a hallmark concern: odontoid hypoplasia/non-fusion increases risk of cervical instability and neurologic compromise (morales2025theuseof pages 38-42, morales2025theuseof pages 42-47, terhal2015astudyof pages 3-4)
Phenotype (HP) systemic skeletal phenotype abnormal endochondral ossification vertebral and appendicular skeleton growth plate chondrocyte spine and long bones short stature (HP:0004322); platyspondyly (HP:0000926); metaphyseal irregularity/metaphyseal flaring; scoliosis N/A In the 93-patient COL2A1 cohort, 80/93 had short stature and SEMD cases were present; odontoid hypoplasia and cervical instability were common across related phenotypes (terhal2015astudyof pages 3-4, terhal2015astudyof pages 4-6)
Phenotype (HP) ocular involvement extracellular matrix organization in vitreous vitreous extracellular matrix vitreous-associated collagen-producing cells eye/vitreous body myopia (HP:0000545); retinal detachment (HP:0000541) N/A Extra-skeletal features reflect type II collagen expression beyond cartilage; myopia and retinal detachment are recurrent in COL2A1 cohorts (nenna2019col2a1genemutations pages 2-3, handa2021radiologicfeaturesof pages 2-3, terhal2015astudyof pages 3-4)
Phenotype (HP) auditory involvement connective tissue maintenance in inner ear extracellular matrix inner ear supporting cells (broadly) inner ear hearing impairment (HP:0000365) N/A Hearing loss is part of the type II collagenopathy spectrum and was present in 37% of the 93-patient cohort (handa2021radiologicfeaturesof pages 2-3, terhal2015astudyof pages 3-4)
Chemical entity (CHEBI/other) glycine; cysteine substitutions in collagen helix collagen trimer stabilization/folding triple-helical domain of procollagen-II chondrocyte (CL:0000138) cartilage variable severity across COL2A1 phenotypes glycine; cysteine Glycine substitutions are the dominant recurrent pathogenic class in COL2A1 skeletal dysplasia; Arg→Cys and other substitutions can also slow folding and perturb matrix assembly (nenna2019col2a1genemutations pages 2-3, barathouari2016theexpandingspectrum pages 1-2, yammine2024humancartilagemodel pages 4-7)
Chemical entity (CHEBI/other) BiP/HSPA5-interacting proteostasis network; caspases protein quality control; apoptosis ER lumen; cytosol chondrocyte (CL:0000138) cartilage chondrocyte apoptosis; cartilage degeneration BiP; caspases Recent models suggest some mutant procollagens evade normal BiP/UPR sensing, whereas broader review evidence supports caspase/CHOP-linked apoptosis when ER stress is unresolved (yammine2023erprocollagenstorage pages 15-18, yammine2024humancartilagemodel pages 1-4, aljuid2026col2a1mutationsand pages 7-8)

Table: This table summarizes ontology-ready molecular, cellular, anatomical, and phenotypic annotations for COL2A1-related spondyloepimetaphyseal dysplasia Strudwick type. It highlights the main mechanistic axis from mutant collagen II proteostasis defects to extracellular matrix disorganization, growth-plate dysfunction, and characteristic skeletal and extraskeletal phenotypes.

Evidence items (PMIDs when available)

The retrieved full-text evidence provided DOIs/URLs and did not include PMIDs in the excerpts for most key items; therefore PMIDs are not reported here. Key evidence sources (with publication date and URL/DOI from the retrieved texts): - Terhal et al., 2015-03, Am J Med Genet A: https://doi.org/10.1002/ajmg.a.36922 (cohort statistics, includes SEMD n=5). (terhal2015astudyof pages 4-6, terhal2015astudyof pages 3-4) - Handa et al., 2021-01, RadioGraphics: https://doi.org/10.1148/rg.2021200075 (radiologic family classification; extraskeletal features). (handa2021radiologicfeaturesof pages 2-3) - Yammine et al., 2024-10 (BioRxiv), https://doi.org/10.1101/2023.10.19.562780 (Gly1170Ser ER storage uncoupled from UPR; proteostasis engagement; therapeutic implications). (yammine2023erprocollagenstorage pages 1-5, yammine2023erprocollagenstorage pages 15-18) - Yammine et al., 2024-11 (BioRxiv), https://doi.org/10.1101/2024.11.07.622468 (Arg719Cys matrix sparsity; ER distention; limited proteostasis recognition). (yammine2024humancartilagemodel pages 4-7, yammine2024humancartilagemodel pages 1-4) - Machol et al., 2017-11, Am J Med Genet A: https://doi.org/10.1002/ajmg.a.38059 (explicit OMIM 184250 linkage and AD inheritance context). (machol2017cornerfracturetype pages 4-5)

Limitations of this tool-based review

  • MONDO/Orphanet identifiers and PMIDs were not present in the retrieved evidence snippets; thus they are not asserted here.
  • 2023–2024 sources in the retrieved evidence set are primarily mechanistic preprints (BioRxiv) rather than final peer-reviewed publications; however, they directly address the requested molecular/cellular pathophysiology with high mechanistic resolution. (yammine2023erprocollagenstorage pages 1-5, yammine2024humancartilagemodel pages 1-4)

References

  1. (aljuid2026col2a1mutationsand pages 7-8): Latifa Mohammed Aljuid, Dareen Alyousfi, Manal Hosawi, and Ayman Z Elsamanoudy. Col2a1 mutations and type ii collagenopathies: molecular mechanisms and ipsc-based modeling of cartilage disorders. Archives of Stem Cell and Therapy, 6:6, Feb 2026. URL: https://doi.org/10.46439/stemcell.6.026, doi:10.46439/stemcell.6.026. This article has 0 citations.

  2. (aljuid2026col2a1mutationsand pages 8-9): Latifa Mohammed Aljuid, Dareen Alyousfi, Manal Hosawi, and Ayman Z Elsamanoudy. Col2a1 mutations and type ii collagenopathies: molecular mechanisms and ipsc-based modeling of cartilage disorders. Archives of Stem Cell and Therapy, 6:6, Feb 2026. URL: https://doi.org/10.46439/stemcell.6.026, doi:10.46439/stemcell.6.026. This article has 0 citations.

  3. (yammine2023erprocollagenstorage pages 1-5): Kathryn M. Yammine, Sophia Mirda Abularach, Seo-yeon Kim, Agata A. Bikovtseva, Jinia Lilianty, Vincent L. Butty, Richard P. Schiavoni, John F. Bateman, Shireen R. Lamandé, and Matthew D. Shoulders. Er procollagen storage defect without coupled unfolded protein response drives precocious arthritis. BioRxiv, Oct 2024. URL: https://doi.org/10.1101/2023.10.19.562780, doi:10.1101/2023.10.19.562780. This article has 5 citations.

  4. (yammine2024humancartilagemodel pages 4-7): Kathryn M. Yammine, Sophia Mirda Abularach, Michael Xiong, Seo-yeon Kim, Agata A. Bikovtseva, Vincent L. Butty, Richard P. Schiavoni, John F. Bateman, Shireen R. Lamandé, and Matthew D. Shoulders. Human cartilage model of the precocious osteoarthritis-inducingcol2a1p.arg719cys reveals pathology-driving matrix defects and a failure of the er proteostasis network to recognize the defective procollagen-ii. BioRxiv, Nov 2024. URL: https://doi.org/10.1101/2024.11.07.622468, doi:10.1101/2024.11.07.622468. This article has 1 citations.

  5. (machol2017cornerfracturetype pages 4-5): Keren Machol, Mahim Jain, Mohammed Almannai, Thibault Orand, James T. Lu, Alyssa Tran, Yuqing Chen, Alan Schlesinger, Richard Gibbs, Luisa Bonafe, Ana Belinda Campos‐Xavier, Sheila Unger, Andrea Superti‐Furga, Brendan H. Lee, Philippe M. Campeau, and Lindsay C. Burrage. Corner fracture type spondylometaphyseal dysplasia: overlap with type ii collagenopathies. American Journal of Medical Genetics Part A, 173:733-739, Nov 2017. URL: https://doi.org/10.1002/ajmg.a.38059, doi:10.1002/ajmg.a.38059. This article has 14 citations.

  6. (morales2025theuseof pages 42-47): LC Vertel Morales. The use of human induced pluripotent stem cells to model type 2 collagenopathies. Unknown journal, 2025.

  7. (handa2021radiologicfeaturesof pages 2-3): Atsuhiko Handa, Giedre Grigelioniene, and Gen Nishimura. Radiologic features of type ii and type xi collagenopathies. RadioGraphics, 41:192-209, Jan 2021. URL: https://doi.org/10.1148/rg.2021200075, doi:10.1148/rg.2021200075. This article has 19 citations and is from a domain leading peer-reviewed journal.

  8. (nenna2019col2a1genemutations pages 2-3): Raffaella Nenna, Arianna Turchetti, Gerarda Mastrogiorgio, and Fabio Midulla. Col2a1 gene mutations: mechanisms of spondyloepiphyseal dysplasia congenita. The Application of Clinical Genetics, 12:235-238, Dec 2019. URL: https://doi.org/10.2147/tacg.s197205, doi:10.2147/tacg.s197205. This article has 51 citations.

  9. (yammine2023erprocollagenstorage pages 15-18): Kathryn M. Yammine, Sophia Mirda Abularach, Seo-yeon Kim, Agata A. Bikovtseva, Jinia Lilianty, Vincent L. Butty, Richard P. Schiavoni, John F. Bateman, Shireen R. Lamandé, and Matthew D. Shoulders. Er procollagen storage defect without coupled unfolded protein response drives precocious arthritis. BioRxiv, Oct 2024. URL: https://doi.org/10.1101/2023.10.19.562780, doi:10.1101/2023.10.19.562780. This article has 5 citations.

  10. (yammine2024humancartilagemodel pages 1-4): Kathryn M. Yammine, Sophia Mirda Abularach, Michael Xiong, Seo-yeon Kim, Agata A. Bikovtseva, Vincent L. Butty, Richard P. Schiavoni, John F. Bateman, Shireen R. Lamandé, and Matthew D. Shoulders. Human cartilage model of the precocious osteoarthritis-inducingcol2a1p.arg719cys reveals pathology-driving matrix defects and a failure of the er proteostasis network to recognize the defective procollagen-ii. BioRxiv, Nov 2024. URL: https://doi.org/10.1101/2024.11.07.622468, doi:10.1101/2024.11.07.622468. This article has 1 citations.

  11. (yeter2025diagnosticchallengeof pages 5-12): Burcu Yeter, Yasemin Kendir Demirkol, Metin Eser, Ahmet Hamdi Akgülle, Betül Sözeri, and Heves Kırmızıbekmez. Diagnostic challenge of phenotypic variability in col2a1-related disorders: four novel variants and expanding the clinical spectrum. Journal of clinical research in pediatric endocrinology, Jan 2025. URL: https://doi.org/10.4274/jcrpe.galenos.2025.2024-9-7, doi:10.4274/jcrpe.galenos.2025.2024-9-7. This article has 0 citations.

  12. (morales2025theuseof pages 38-42): LC Vertel Morales. The use of human induced pluripotent stem cells to model type 2 collagenopathies. Unknown journal, 2025.

  13. (terhal2015astudyof pages 3-4): Paulien A. Terhal, Rutger Jan A. J. Nievelstein, Eva J. J. Verver, Vedat Topsakal, Paula van Dommelen, Kristien Hoornaert, Martine Le Merrer, Andreas Zankl, Marleen E. H. Simon, Sarah F. Smithson, Carlo Marcelis, Bronwyn Kerr, Jill Clayton‐Smith, Esther Kinning, Sahar Mansour, Frances Elmslie, Linda Goodwin, Annemarie H. van der Hout, Hermine E. Veenstra‐Knol, Johanna C. Herkert, Allan M. Lund, Raoul C. M. Hennekam, André Mégarbané, Melissa M. Lees, Louise C. Wilson, Alison Male, Jane Hurst, Yasemin Alanay, Göran Annerén, Regina C. Betz, Ernie M. H. F. Bongers, Valerie Cormier‐Daire, Anne Dieux, Albert David, Mariet W. Elting, Jenneke van den Ende, Andrew Green, Johanna M. van Hagen, Niels Thomas Hertel, Muriel Holder‐Espinasse, Nicolette den Hollander, Tessa Homfray, Hanne D. Hove, Susan Price, Annick Raas‐Rothschild, Marianne Rohrbach, Barbara Schroeter, Mohnish Suri, Elizabeth M. Thompson, Edward S. Tobias, Annick Toutain, Maaike Vreeburg, Emma Wakeling, Nine V. Knoers, Paul Coucke, and Geert R. Mortier. A study of the clinical and radiological features in a cohort of 93 patients with a col2a1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. American Journal of Medical Genetics Part A, 167:461-475, Mar 2015. URL: https://doi.org/10.1002/ajmg.a.36922, doi:10.1002/ajmg.a.36922. This article has 105 citations.

  14. (terhal2015astudyof pages 4-6): Paulien A. Terhal, Rutger Jan A. J. Nievelstein, Eva J. J. Verver, Vedat Topsakal, Paula van Dommelen, Kristien Hoornaert, Martine Le Merrer, Andreas Zankl, Marleen E. H. Simon, Sarah F. Smithson, Carlo Marcelis, Bronwyn Kerr, Jill Clayton‐Smith, Esther Kinning, Sahar Mansour, Frances Elmslie, Linda Goodwin, Annemarie H. van der Hout, Hermine E. Veenstra‐Knol, Johanna C. Herkert, Allan M. Lund, Raoul C. M. Hennekam, André Mégarbané, Melissa M. Lees, Louise C. Wilson, Alison Male, Jane Hurst, Yasemin Alanay, Göran Annerén, Regina C. Betz, Ernie M. H. F. Bongers, Valerie Cormier‐Daire, Anne Dieux, Albert David, Mariet W. Elting, Jenneke van den Ende, Andrew Green, Johanna M. van Hagen, Niels Thomas Hertel, Muriel Holder‐Espinasse, Nicolette den Hollander, Tessa Homfray, Hanne D. Hove, Susan Price, Annick Raas‐Rothschild, Marianne Rohrbach, Barbara Schroeter, Mohnish Suri, Elizabeth M. Thompson, Edward S. Tobias, Annick Toutain, Maaike Vreeburg, Emma Wakeling, Nine V. Knoers, Paul Coucke, and Geert R. Mortier. A study of the clinical and radiological features in a cohort of 93 patients with a col2a1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. American Journal of Medical Genetics Part A, 167:461-475, Mar 2015. URL: https://doi.org/10.1002/ajmg.a.36922, doi:10.1002/ajmg.a.36922. This article has 105 citations.

  15. (terhal2015astudyof media 7e789bd0): Paulien A. Terhal, Rutger Jan A. J. Nievelstein, Eva J. J. Verver, Vedat Topsakal, Paula van Dommelen, Kristien Hoornaert, Martine Le Merrer, Andreas Zankl, Marleen E. H. Simon, Sarah F. Smithson, Carlo Marcelis, Bronwyn Kerr, Jill Clayton‐Smith, Esther Kinning, Sahar Mansour, Frances Elmslie, Linda Goodwin, Annemarie H. van der Hout, Hermine E. Veenstra‐Knol, Johanna C. Herkert, Allan M. Lund, Raoul C. M. Hennekam, André Mégarbané, Melissa M. Lees, Louise C. Wilson, Alison Male, Jane Hurst, Yasemin Alanay, Göran Annerén, Regina C. Betz, Ernie M. H. F. Bongers, Valerie Cormier‐Daire, Anne Dieux, Albert David, Mariet W. Elting, Jenneke van den Ende, Andrew Green, Johanna M. van Hagen, Niels Thomas Hertel, Muriel Holder‐Espinasse, Nicolette den Hollander, Tessa Homfray, Hanne D. Hove, Susan Price, Annick Raas‐Rothschild, Marianne Rohrbach, Barbara Schroeter, Mohnish Suri, Elizabeth M. Thompson, Edward S. Tobias, Annick Toutain, Maaike Vreeburg, Emma Wakeling, Nine V. Knoers, Paul Coucke, and Geert R. Mortier. A study of the clinical and radiological features in a cohort of 93 patients with a col2a1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. American Journal of Medical Genetics Part A, 167:461-475, Mar 2015. URL: https://doi.org/10.1002/ajmg.a.36922, doi:10.1002/ajmg.a.36922. This article has 105 citations.

  16. (terhal2015astudyof media 98be3c29): Paulien A. Terhal, Rutger Jan A. J. Nievelstein, Eva J. J. Verver, Vedat Topsakal, Paula van Dommelen, Kristien Hoornaert, Martine Le Merrer, Andreas Zankl, Marleen E. H. Simon, Sarah F. Smithson, Carlo Marcelis, Bronwyn Kerr, Jill Clayton‐Smith, Esther Kinning, Sahar Mansour, Frances Elmslie, Linda Goodwin, Annemarie H. van der Hout, Hermine E. Veenstra‐Knol, Johanna C. Herkert, Allan M. Lund, Raoul C. M. Hennekam, André Mégarbané, Melissa M. Lees, Louise C. Wilson, Alison Male, Jane Hurst, Yasemin Alanay, Göran Annerén, Regina C. Betz, Ernie M. H. F. Bongers, Valerie Cormier‐Daire, Anne Dieux, Albert David, Mariet W. Elting, Jenneke van den Ende, Andrew Green, Johanna M. van Hagen, Niels Thomas Hertel, Muriel Holder‐Espinasse, Nicolette den Hollander, Tessa Homfray, Hanne D. Hove, Susan Price, Annick Raas‐Rothschild, Marianne Rohrbach, Barbara Schroeter, Mohnish Suri, Elizabeth M. Thompson, Edward S. Tobias, Annick Toutain, Maaike Vreeburg, Emma Wakeling, Nine V. Knoers, Paul Coucke, and Geert R. Mortier. A study of the clinical and radiological features in a cohort of 93 patients with a col2a1 mutation causing spondyloepiphyseal dysplasia congenita or a related phenotype. American Journal of Medical Genetics Part A, 167:461-475, Mar 2015. URL: https://doi.org/10.1002/ajmg.a.36922, doi:10.1002/ajmg.a.36922. This article has 105 citations.

  17. (aljuid2026col2a1mutationsand pages 6-7): Latifa Mohammed Aljuid, Dareen Alyousfi, Manal Hosawi, and Ayman Z Elsamanoudy. Col2a1 mutations and type ii collagenopathies: molecular mechanisms and ipsc-based modeling of cartilage disorders. Archives of Stem Cell and Therapy, 6:6, Feb 2026. URL: https://doi.org/10.46439/stemcell.6.026, doi:10.46439/stemcell.6.026. This article has 0 citations.

  18. (barathouari2016theexpandingspectrum pages 1-2): Mouna Barat-Houari, Bruno Dumont, Aurélie Fabre, Frédéric TM Them, Yves Alembik, Jean-Luc Alessandri, Jeanne Amiel, Séverine Audebert, Clarisse Baumann-Morel, Patricia Blanchet, Eric Bieth, Marie Brechard, Tiffany Busa, Patrick Calvas, Yline Capri, François Cartault, Nicolas Chassaing, Vidrica Ciorca, Christine Coubes, Albert David, Anne-Lise Delezoide, Delphine Dupin-Deguine, Salima El Chehadeh, Laurence Faivre, Fabienne Giuliano, Alice Goldenberg, Bertrand Isidor, Marie-Line Jacquemont, Sophie Julia, Josseline Kaplan, Didier Lacombe, Marine Lebrun, Sandrine Marlin, Dominique Martin-Coignard, Jelena Martinovic, Alice Masurel, Judith Melki, Monique Mozelle-Nivoix, Karine Nguyen, Sylvie Odent, Nicole Philip, Lucile Pinson, Ghislaine Plessis, Chloé Quélin, Elise Shaeffer, Sabine Sigaudy, Christel Thauvin, Marianne Till, Renaud Touraine, Jacqueline Vigneron, Geneviève Baujat, Valérie Cormier-Daire, Martine Le Merrer, David Geneviève, and Isabelle Touitou. The expanding spectrum of col2a1 gene variants in 136 patients with a skeletal dysplasia phenotype. European Journal of Human Genetics, 24:992-1000, Dec 2016. URL: https://doi.org/10.1038/ejhg.2015.250, doi:10.1038/ejhg.2015.250. This article has 54 citations and is from a domain leading peer-reviewed journal.

Perplexity ▸
Pathophysiology of Spondyloepimetaphyseal Dysplasia Strudwick Type: A Comprehensive Analysis of Type II Collagenopathy Mechanisms
sonar-deep-research 52 citations 2026-02-04T18:10:09.429872

Pathophysiology of Spondyloepimetaphyseal Dysplasia Strudwick Type: A Comprehensive Analysis of Type II Collagenopathy Mechanisms

Spondyloepimetaphyseal dysplasia Strudwick type (SEMD-S) is a rare autosomal dominant skeletal dysplasia caused by mutations in the COL2A1 gene, resulting in defective type II collagen assembly that leads to severe skeletal abnormalities, including disproportionate short stature with very short trunk and shortened limbs, progressive spinal deformities with kyphoscoliosis and lordosis, metaphyseal dysplasia with characteristic "dappled" or flocculated appearance, and ocular complications including high myopia and retinal detachment[1][3][6]. The pathophysiology of SEMD-S encompasses multiple interconnected levels of biological disruption, from aberrant collagen triple helix formation at the molecular level through endoplasmic reticulum stress and chondrocyte apoptosis at the cellular level, culminating in disrupted endochondral ossification and widespread skeletal dysplasia at the tissue and organismal level. This comprehensive analysis examines the mechanistic basis of this complex collagenopathy, synthesizing current understanding of type II collagen biochemistry, cellular responses to protein misfolding, growth plate biology, and the cascade of events leading from genetic mutation to clinical disease manifestation.

Molecular Basis of Type II Collagenopathies: COL2A1 Gene Structure and Function

The COL2A1 gene, located on chromosome 12q13, encodes the alpha-1(II) chain, which constitutes the structural foundation of type II collagen, the predominant collagen in cartilage and the vitreous humor[1][7]. Type II collagen is essential for the normal development of bones and other connective tissues that form the body's supportive framework, as it provides the structural scaffold necessary for both embryonic skeletal development and postnatal growth[1]. Understanding the fundamental structure and function of type II collagen is prerequisite to comprehending how COL2A1 mutations lead to SEMD-S pathology. To construct functional type II collagen, three alpha-1(II) chains twist together to form a procollagen molecule, which is then processed by enzymes within the cell to generate mature collagen molecules that arrange themselves into long, thin fibrils that cross-link with one another in a lattice pattern in the spaces around cells[7]. This mature collagen fibril formation is absolutely critical for the mechanical stability and biological function of cartilaginous tissues that bear compressive loads.

The triple helix of type II collagen exhibits a highly specific structural motif based on the repetitive amino acid sequence glycine-X-Y, where glycine occupies every third position in each chain[43][46]. This structural requirement exists because the center of the collagen triple helix is extremely small and hydrophobic, with only the tiny hydrogen side chain of glycine capable of fitting within this restricted central cavity[43]. The X and Y positions of the tripeptide repeat are frequently occupied by proline and hydroxyproline residues, respectively, which provide additional stability to the triple helix through their pyrrolidine ring structures and hydrogen bonding interactions[43]. The rise of the collagen triple helix is 2.9 Ångströms per residue, and three left-handed helical strands wind around each other with precise geometric spacing to form the characteristic right-handed triple helix[43]. Each of the three chains is stabilized by both steric repulsion due to proline and hydroxyproline pyrrolidine rings and by hydrogen bonds between chains, wherein peptide NH groups of glycine residues serve as hydrogen bond donors and carbonyl groups on other chains serve as acceptors[43].

Type II collagen is synthesized as procollagen molecules featuring an extended triple-helical domain flanked by globular N-terminal and C-terminal propeptides[8][5]. The biosynthesis of procollagen involves complex posttranslational modifications of the nascent pro-α chains, including hydroxylation of proline and lysine residues by prolyl-4-hydroxylase and lysyl-hydroxylase, respectively[8]. These modifications are essential for establishing the proper thermal stability of the triple helix and for enabling subsequent cross-linking of collagen molecules in the extracellular matrix. Once procollagen molecules are properly folded and modified within the endoplasmic reticulum (ER), they must be transported through the secretory pathway for further processing and assembly into the organized collagen fibril networks that form the extracellular matrix scaffold of cartilage and bone.

COL2A1 Mutations and Classification into Molecular Mechanisms

Over 700 patients have been documented with COL2A1 mutations, harboring more than 415 different mutations comprising over 400 pathogenic variants and variants of uncertain significance[5][9][57]. These mutations exhibit remarkable heterogeneity in their molecular nature, including point mutations (missense, nonsense, deletions, insertions, indels, and frame-shift mutations) as well as complex rearrangements[5][56]. Critically, no mutational hot spots have been identified within the COL2A1 gene, indicating that pathogenic variants can occur throughout the gene sequence, though the nature and localization of mutations correlate with phenotypic severity[5][9]. The severity of the phenotype associated with COL2A1 mutations is explained by the nature of the mutation itself and its precise localization within the collagen protein sequence.

Type II collagenopathies follow two distinct molecular pathogenic mechanisms: dominant-negative effects and haploinsufficiency[5][9][56]. Missense mutations constitute the most common class of COL2A1 alterations, representing over 70% of reported variants[5][56]. Among missense mutations, those that result in substitution of glycine residues within the critical Gly-X-Y repeats of the triple helix present as dominant-negative mutations that disrupt the collagen triple helix and are commonly found in the more severe phenotypes, including achondrogenesis type II, hypochondrogenesis, and SEMD-S[5][9][56]. The dominant-negative effect arises because even a single mutant alpha-1(II) chain incorporated into a trimeric collagen molecule can destabilize the entire triple helix structure, since the three chains are intricately intertwined throughout the helical domain[5][9]. Approximately one-third of all COL2A1 mutations are dominant-negative mutations affecting glycine residues in the G-X-Y repeats[57].

In contrast, haploinsufficiency results from nonsense mutations, out-of-frame deletions, and splice site mutations that result in premature stop codons, leading to degradation of aberrant transcripts through nonsense-mediated decay mechanisms and consequent reduced synthesis of normal type II collagen[5][9][56]. These haploinsufficiency mutations are generally associated with milder phenotypes, as they reduce the total amount of functional collagen available rather than introducing structurally disruptive collagen molecules that poison the assembly process[5][9]. Missense mutations that result in substitution of non-glycine amino acids in the triple helix typically produce milder phenotypes compared to glycine substitutions, as they cause impairment in protein stability and destabilization of the helical structure without entirely disrupting assembly[5][9][56]. Additionally, the specific anatomical location of mutations within the COL2A1 gene correlates with phenotypic severity: mutations in the C-propeptide region tend to produce severe and often lethal phenotypes, while mutations in the N-propeptide region, particularly in exon 2, result in milder symptoms[60].

Structural Consequences of COL2A1 Mutations in SEMD-S

SEMD-S is typically caused by missense mutations resulting in glycine-to-amino acid substitutions within the triple helical domain of type II collagen[2][26]. Early biochemical characterization of COL2A1 mutations in SEMD-S patients demonstrated that defective alpha-1(II) collagen chains exhibit altered electrophoretic mobility, relatively low thermostability, and slow rates of secretion into the extracellular space[5]. The mutant collagen molecules self-assemble into abnormal fibrils that are unable to properly interact with other elements of the extracellular matrix, fundamentally compromising the structural integrity of cartilage[5]. Heterozygous mutations lead to production of abnormal alpha-1(II) chains that associate with normal alpha-1(II) chains, creating a mismatch that results in abnormal versions of type II collagen that cannot function properly[5][7].

At the biochemical level, glycine substitution mutations in the Gly-X-Y repeats interfere with the conversion of type II procollagen to mature collagen and impair the intracellular transport and secretion of the molecule[27]. The glycine substitution appears to disrupt proper triple helix formation, leading to kinetically unfavorable assembly that results in retention of misfolded procollagen molecules within the endoplasmic reticulum[27]. This retention of abnormal collagen in the ER represents a critical point in the pathophysiological cascade, as accumulated misfolded protein triggers cellular stress responses that ultimately lead to chondrocyte dysfunction and death.

Endoplasmic Reticulum Stress and the Unfolded Protein Response in SEMD-S

The accumulation of misfolded type II procollagen within the endoplasmic reticulum represents a critical triggering event in SEMD-S pathophysiology, initiating the unfolded protein response (UPR), a conserved cellular survival and death signaling pathway[8][31][32]. The endoplasmic reticulum is the primary site of synthesis, modification, and folding of secreted proteins, including procollagen, and maintains specialized intra-ER conditions featuring adenosine triphosphate (ATP), calcium ions, unique oxidizing conditions, and molecular chaperone proteins necessary for proper protein folding[8]. When the load of unfolded or misfolded proteins exceeds the processing capacity of the endoplasmic reticulum, an imbalance termed endoplasmic reticulum (ER) stress develops, leading to activation of the UPR[8][31]. The UPR functions as a three-armed signaling pathway initiated by three transmembrane ER stress transducers: protein kinase RNA-like endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1 alpha (IRE1α), and activating transcription factor 6 (ATF6)[31][35].

Under normal conditions, these three ER stress transducers are kept inactive through binding to the ER-resident chaperone protein glucose-regulated protein 78 (GRP78, also called BiP)[31][35]. When unfolded or misfolded proteins accumulate in the ER lumen, bound GRP78 dissociates from the three stress transducers to bind exposed hydrophobic residues on aberrant proteins, disrupting the GRP78-transducer interactions and initiating downstream signaling through all three arms of the UPR[8][31][35]. The PERK arm is particularly significant in the context of SEMD-S and other chondrodysplasias. Upon ER stress, PERK autophosphorylates and then phosphorylates the eukaryotic initiation factor 2 alpha (eIF2α) at serine 51, leading to a marked elevation in phosphorylated eIF2α levels[35]. This phosphorylation results in inhibition of the eIF2B guanine nucleotide exchange factor, effectively blocking the formation of ternary complexes required for translation initiation, thereby causing rapid global attenuation of new protein synthesis to reduce the ER protein load and allow adaptation to stress conditions[35].

Simultaneously, phosphorylation of eIF2α promotes selective translation of specific mRNAs containing upstream open reading frames in their 5' untranslated regions, most notably the mRNA encoding activating transcription factor 4 (ATF4)[35]. ATF4 is a transcription factor that regulates numerous genes involved in cell adaptation to stress conditions, including genes encoding amino acid synthesis enzymes, nutrient uptake transporters, and antioxidant defense proteins[35]. However, under conditions of prolonged or severe ER stress that SEMD-S mutations appear to induce, the PERK/eIF2α/ATF4 signaling pathway proceeds to activate CCAAT/enhancer binding protein homologous protein (CHOP), also termed growth arrest and DNA damage-inducible gene 135 (GADD135)[32][35]. CHOP, also activated through the ATF6 arm of the UPR, acts as a pro-apoptotic transcription factor that promotes expression of genes driving programmed cell death, including death receptor ligands, B-cell lymphoma-2 (Bcl-2) family pro-apoptotic proteins, and various other apoptosis-promoting factors[31][35].

Studies employing transgenic mouse models of type II collagen mutations have provided compelling evidence for the critical role of ER stress and the UPR in SEMD-S pathogenesis. Investigations of a col2a1 mouse model harboring the p.Gly1170Ser mutation revealed that misfolded procollagen was largely synthesized and retained in dilated endoplasmic reticulum, with activation of the ER stress-UPR-apoptosis cascade[34]. In homozygous mutants carrying two copies of the mutated allele, the stress was severe enough to trigger apoptosis, with proliferative chondrocytes undergoing programmed cell death before they could differentiate into hypertrophic chondrocytes, ultimately causing disordered growth plates and chondrodysplasia[34]. Notably, heterozygous mice carrying only one mutated allele maintained limited ER stress intensity without abnormal apoptosis, and the normal growth plate structure and endochondral ossification process were maintained[34]. This observation parallels the human genetic situation, where heterozygous COL2A1 mutations cause SEMD-S, suggesting that the cellular stress from abnormal collagen production, while severe, can typically be tolerated at the heterozygous level but manifests severe pathology when combined with other cellular stressors.

Integrated Stress Response Signaling in Chondrocyte Differentiation Disruption

Recent research has elucidated the molecular mechanisms through which ER stress-induced signaling disrupts the normal differentiation program of chondrocytes in type II collagenopathies, particularly metaphyseal chondrodysplasia Schmid type (MCDS), a related condition caused by mutations in COL10A1[32]. This integrated stress response (ISR) pathway, centered on PERK-mediated phosphorylation of eIF2α and preferential translation of ATF4, has been shown to revert chondrocyte differentiation to a more juvenile state through direct transactivation of SOX9, a critical transcription factor for chondrocyte identity[32]. Remarkably, abnormal chondrocyte differentiation can be ameliorated by pharmacological inhibition of PERK signaling, preventing the differentiation defects and ameliorating chondrodysplasia in mutant mice[32]. This finding suggests that therapeutic targeting of the ISR pathway may represent a rational therapeutic strategy for treating SEMD-S and related type II collagenopathies.

Chondrocyte Dysfunction and Growth Plate Disorganization

The primary cellular target of type II collagen defects in SEMD-S is the chondrocyte, the sole cell type that produces and maintains the extracellular matrix of cartilage[13][16]. Chondrocytes are highly specialized mesenchymal cells that synthesize large quantities of extracellular matrix components, including type II collagen, proteoglycans such as aggrecan, and various other matrix proteins and glycosaminoglycans[13][16]. In the growth plate, chondrocytes progress through a carefully orchestrated developmental program characterized by distinct morphological and functional phases: the resting zone containing quiescent chondrocytes, the proliferative zone where chondrocytes actively divide and organize into columns, the prehypertrophic zone where cells cease dividing and begin differentiation, the hypertrophic zone where cells enlarge dramatically and undergo terminal differentiation, and the calcification and ossification zones where the cartilage matrix mineralizes and is replaced by bone[16][50][53].

Histopathological examination of cartilage from patients and animal models with type II collagen mutations reveals disorganization of the normal growth plate architecture[5][27][39]. Studies have documented poorly organized growth plates with clustering of chondrocytes, sparse cartilage matrix, and extensive fibrous tissue associated with vascular canals[27]. Transmission electron microscopy has revealed distended rough endoplasmic reticulum within most epiphyseal chondrocytes and irregular thickening of collagen fibrils compared with normal controls[27]. The relative amount of cartilage matrix is reduced compared to normal, and the collagen fibrils that are present are thickened and unevenly distributed, indicating fundamental defects in matrix organization[27].

The abnormal collagen misfolding and ER retention in SEMD-S leads to multiple layers of cellular dysfunction. First, the excessive intracellular accumulation of misfolded procollagen induces endoplasmic reticulum stress sufficient to reduce proliferation rates at the growth plates[5]. Second, the absence or marked reduction in the messenger RNA (mRNA) expression of critical chondrocyte markers, including cyclin-dependent kinase inhibitor 1a (Cdkn1a), Indian hedgehog (Ihh), fibroblast growth factor receptor 3 (Fgfr3), type X collagen (COL10A1), and runt-related transcription factor 2 (Runx2), has been reported[5]. This abnormal chondrocyte differentiation negatively affects linear bone growth by altering the normal relationships between cells and the provision of growth factors during endochondral ossification[5].

Role of Indian Hedgehog Signaling in SEMD-S Pathophysiology

Indian hedgehog (Ihh) signaling represents a critical regulatory mechanism in endochondral ossification and growth plate maintenance that is disrupted in type II collagenopathies[36][33]. Ihh is produced by prehypertrophic and hypertrophic chondrocytes and acts through a paracrine negative feedback mechanism to regulate chondrocyte maturation by maintaining expression of parathyroid hormone-related peptide (PTHrP), which inhibits the differentiation of resting chondrocytes into proliferating chondrocytes[33][36]. This Ihh-PTHrP feedback loop is essential for maintaining the proper size and cellular composition of the proliferative zone, ensuring coordinated bone growth. Studies utilizing conditional knockout approaches have demonstrated that Ihh expression in postnatal chondrocytes is essential for maintenance of the growth plate and for sustaining the primary spongiosa and eventual bone growth after birth[36].

In the setting of type II collagen mutations causing SEMD-S, the disruption of normal chondrocyte function appears to impair the Ihh-PTHrP signaling axis. Loss of Ihh signaling in chondrocytes has been shown to cause loss of the chondrocyte columnar structure, formation of ectopic hypertrophic chondrocytes, and premature vascular invasion, leading to premature fusion of the growth plate and dwarfism associated with loss of trabecular bone over time[16]. The reduced expression of Ihh observed in chondrocytes synthesizing abnormal type II collagen, combined with ER stress-induced alterations in chondrocyte gene expression, likely contributes to the disrupted growth plate architecture characteristic of SEMD-S.

Vascular Endothelial Growth Factor and Angiogenic Signaling

Vascular endothelial growth factor (VEGF) plays a crucial role in coupling hypertrophic cartilage remodeling, ossification, and angiogenesis during endochondral bone formation[50][45]. VEGF is synthesized by hypertrophic chondrocytes in the growth plate and is released into the surrounding environment, where it acts both as a paracrine factor to recruit invading endothelial cells and as an autocrine factor to promote chondrocyte hypertrophy and differentiation[45][50]. Studies have demonstrated that VEGF is distinctly localized to growth plate hypertrophic chondrocytes immediately before vascular invasion, and that VEGF receptor 2 (VEGFR2) colocalizes with VEGF in both hypertrophic cartilage in vivo and in engineered hypertrophic cartilage in vitro, suggesting autocrine activation of VEGF signaling[45][50]. The VEGF/VEGFR2 signaling pathway is essential for inducing the vascular invasion that allows osteoblasts, osteoclasts, and bone marrow components to access the calcified cartilage matrix and replace it with organized bone tissue[45][50].

In the context of SEMD-S, the disruption of normal hypertrophic chondrocyte function and the premature apoptosis induced by ER stress appear to impair VEGF production and signaling, potentially contributing to delayed or abnormal vascular invasion of the growth plate and consequent disruption of the ossification process. The disordered growth plates and sparse trabecular bone observed in SEMD-S likely reflect, in part, this impaired angiogenic signaling.

Chondrocyte Apoptosis and Growth Plate Failure

Chondrocytes of the growth plate undergo apoptosis as a normal part of endochondral ossification, particularly in the hypertrophic zone where terminally differentiated cells die to make way for vascular invasion and bone formation[31][50]. However, in SEMD-S and other type II collagenopathies, the ER stress-induced premature and excessive apoptosis of proliferating chondrocytes disrupts this carefully orchestrated process[34]. The study of the col2a1 p.Gly1170Ser mouse model demonstrated that activated caspase-3 and apoptotic cells were significantly increased in the growth plates of homozygous mutants, and this increased apoptosis was specifically localized to the proliferative zone, where it prevented chondrocytes from maturing into hypertrophic cells[34]. This premature loss of proliferating chondrocytes leads to a hypertrophic zone that is reduced in size or completely absent, fundamentally disrupting endochondral ossification and resulting in the severe dwarfism and skeletal dysplasia characteristic of SEMD-S.

The increased apoptosis appears to be mediated through multiple pathways. The PERK/eIF2α/ATF4/CHOP signaling cascade promotes apoptosis through several mechanisms: direct transactivation of pro-apoptotic genes by CHOP, suppression of synthesis of anti-apoptotic Bcl-2 family proteins, and induction of ER stress-mediated leakage of calcium into the cytoplasm that activates death effectors[31][35]. Additionally, the aberrant differentiation caused by ATF4-mediated transactivation of SOX9 may trigger alternative apoptotic pathways in cells that cannot properly execute the chondrocyte differentiation program. The balance between cell survival and apoptosis appears to be determined by the duration and intensity of eIF2α phosphorylation and ATF4 levels, with prolonged or severe stress tipping the balance toward programmed cell death.

Endochondral Ossification and Linear Bone Growth Disruption

The process of endochondral ossification, through which most bones of the skeleton develop and subsequently elongate postnatally, is fundamentally disrupted in SEMD-S due to the cascading defects in type II collagen structure, chondrocyte function, and growth plate organization[14][16][17]. Endochondral ossification begins with condensation and proliferation of mesenchymal cells in the region where bone will form, followed by differentiation of these cells into chondroblasts that actively synthesize cartilage matrix components[17]. These cells form the initial hyaline cartilage template, which has the same basic shape and outline as the future bone[17]. This cartilage template then expands through both interstitial growth (chondrocyte proliferation and matrix synthesis from within the cartilage) and appositional growth (differentiation of perichondrial cells into chondrocytes on the external cartilage surface)[17].

Ossification commences within the primary ossification center located in the center of the bone shaft (diaphysis), where chondrocytes in the center undergo hypertrophy and cease dividing[17]. These hypertrophic chondrocytes secrete type X collagen (which causes stiffness and compression of the extracellular matrix), matrix metalloproteinases (which degrade cartilage matrix), VEGF (which controls forthcoming vascular invasion), and alkaline phosphatase (which causes calcification of the cartilage matrix)[17][50]. The calcification of the cartilage matrix prevents passage of nutrients to chondrocytes, leading to their death[17]. Subsequently, blood vessels from the periosteum invade these empty spaces, guided by VEGF signaling, bringing mesenchymal stem cells that differentiate into osteoprogenitor cells, which mature into osteoblasts[17][50]. These osteoblasts deposit unmineralized bone matrix (osteoid), which subsequently mineralizes to form bone trabeculae[17].

In SEMD-S, this precisely choreographed process fails at multiple critical junctures. The reduced production and abnormal structure of type II collagen compromises the initial cartilage template formation and its subsequent expansion. The ER stress-induced apoptosis of proliferating chondrocytes reduces the number of cells available to produce the cartilage matrix necessary for both template formation and linear growth. The impaired expression of Ihh and other chondrocyte differentiation markers disrupts the signaling pathways that normally couple chondrocyte proliferation with subsequent differentiation. The disrupted VEGF signaling impairs the angiogenic response necessary for vascular invasion and osteoblast recruitment. The cumulative effect is profound dwarfism with disproportionate short trunk and shortened limbs, as documented clinically in SEMD-S patients.

Structural Manifestations: Skeletal Dysplasia in SEMD-S

The disrupted endochondral ossification in SEMD-S manifests as characteristic skeletal abnormalities affecting both the spine and the long bones. At birth, patients with SEMD-S present with disproportionate short stature, very short trunk, and shortened limbs, though hands and feet are typically average-sized[1][3][6][19]. The vertebral column exhibits characteristic flattening (platyspondyly), representing a reduction in the height of vertebral bodies due to delayed and abnormal ossification[1][3][6][39]. Progressive spinal curvature develops in childhood, manifesting as kyphoscoliosis (combined anterior and lateral spinal curvature) and lumbar lordosis (excessive forward curvature of the lumbar spine)[1][3][6][39].

Radiologically, the metaphyses of the long bones exhibit a striking flocculated or dappled fragmentation pattern consisting of expanded metaphyses with islands of relative sclerosis (calcified areas) interspersed with lucent (less calcified) areas[39][29]. This dappled metaphyseal pattern becomes apparent from approximately age four years onward and is considered one of the most distinctive radiological features that distinguishes SEMD-S from spondyloepiphyseal dysplasia congenita (SEDC), which does not typically exhibit this metaphyseal change[2][29]. The long bones are uniformly short, with delayed epiphyseal ossification resulting in small, flattened, and irregular epiphyses[29][39]. Hip joint abnormalities include coxa vara (inward turning of the upper femur), and the distal femoral and humeral metaphyses are characteristically broad with flaring giving a "dumbell" appearance[29][39].

Spinal complications in SEMD-S can be severe and life-threatening. Instability of the spinal bones in the neck may occur as a result of a hypoplastic (underdeveloped) vertebral body, usually C3, and/or a hypoplastic odontoid peg, increasing the risk of spinal cord damage[1][3][39]. Atlantoaxial instability, representing pathological movement of the first and second cervical vertebrae, represents a particularly serious complication requiring careful monitoring and sometimes surgical stabilization. The severe spinal deformity can compromise respiratory function, leading to restrictive lung disease as documented in clinical case reports of SEMD-S patients[37][40].

Ocular Manifestations: Type II Collagen's Role in the Eye

Type II collagen is found predominantly in two ocular tissues: the cartilaginous structures of the eye and the vitreous humor, the clear gel filling the eyeball[1][7][20]. Consequently, mutations in COL2A1 frequently manifest with ocular complications. In SEMD-S, severe nearsightedness (high myopia) is common, occurring as a result of abnormal eye development due to defective type II collagen in the developing eye structures[1][3][6][19][20]. Additionally, retinal detachment, representing separation of the light-sensitive neural retina from the underlying retinal pigment epithelium, occurs as a complication likely resulting from abnormal vitreous structure and mechanical traction on the retina[1][3][6][19][20].

The vitreous humor is composed substantially of type II collagen along with hyaluronan and other proteoglycans, organized into a highly ordered network that maintains the optical clarity and mechanical properties essential for normal vision[20]. In COL2A1-related disorders, mutations result in either membranous vitreous anomalies (common in certain COL2A1 mutations), hypoplastic vitreous (reduced vitreous volume), or irregular and beaded appearance to the vitreous lamellae[20]. These structural abnormalities of the vitreous likely contribute to visual impairment and increase the risk of retinal detachment through abnormal traction on the retina.

Craniofacial and Other Extraskeletal Manifestations

SEMD-S patients display mild and variable changes in facial features, including flattened cheekbones close to the nose and a relatively round face[1][3][6][39]. Some infants are born with cleft palate, representing an opening in the roof of the mouth, occurring in variable proportions of affected individuals[1][3][6]. These craniofacial manifestations likely result from the impaired endochondral ossification affecting cranial skeletal development, as type II collagen is essential during the formative period of craniofacial skeletal development.

Importantly, intelligence and life expectancy are typically normal in individuals with SEMD-S[3]. The disorder affects boys and girls equally, as COL2A1 is located on an autosome rather than the X chromosome[3][19].

Arthritic Complications and Joint Degenerative Disease

A hallmark feature of SEMD-S is the premature development of osteoarthritis and joint degenerative disease, with arthritis developing early in life in some affected individuals[1][3][6][15]. The disrupted type II collagen structure and the abnormal skeletal development contribute to abnormal joint mechanics and increased stress on articular cartilage, leading to accelerated cartilage degradation and osteoarthritis development. The abnormal joint geometry resulting from skeletal dysplasia (such as coxa vara and valgus/varus deformities) places inappropriate mechanical loads on articular surfaces. Additionally, the ongoing structural defects in type II collagen in articular cartilage predispose to progressive deterioration, as the cartilage matrix lacks the mechanical properties necessary to resist normal compressive and shear forces.

Secondary Respiratory Complications

The severe spinal deformities characteristic of SEMD-S can lead to restrictive lung disease and respiratory compromise. The marked kyphoscoliosis restricts chest wall compliance and impairs respiratory mechanics, leading to progressive hypoventilation and chronic hypercapnic respiratory failure[37][40]. The abnormal spine curvature distorts lung volume by the infoldings of the vertebral column and changing the angulation of the ribs, which impairs chest expansion[37]. The compliance of the respiratory system and respiratory muscle strength are related to the degree of spinal curvature, with severe kyphotic and scoliotic angles (typically greater than 50 degrees, and especially when exceeding 100 degrees) causing marked reduction in respiratory system compliance[37][40]. This restricted lung function results in shallow breathing and impaired clearance of mucus from the airways, creating an environment conducive to recurrent respiratory infections such as pneumonia[40].

Disease Progression and Natural History

SEMD-S presents from birth with characteristic features of dwarfism and skeletal abnormalities. Beginning in infancy, the typical manifestations include short stature with very short trunk and shortened limbs, though hands and feet remain average-sized. During early childhood, the skeletal dysplasia progressively manifests, with the appearance of spinal deformities and the development of the characteristic metaphyseal changes by approximately age four years. The progressive spinal deformities, particularly kyphoscoliosis, gradually develop and can become severe enough to impair pulmonary function and compromise respiratory mechanics.

The joint complications typically develop during late childhood and adolescence, with early-onset osteoarthritis becoming clinically apparent during adulthood. Ocular complications including high myopia manifest early and can progress to retinal detachment, requiring ophthalmologic surveillance and management. Respiratory complications secondary to severe spinal deformity can develop over time, particularly if kyphoscoliosis becomes sufficiently severe. The overall course of the disease is generally progressive, with cumulative complications developing over the first and second decades of life.

Genotype-Phenotype Correlations in SEMD-S

While a clear universal genotype-phenotype relationship has not been established for all COL2A1 mutations, certain patterns have emerged to guide understanding of phenotypic severity based on mutation characteristics[9][60]. Mutations in the C-propeptide region of COL2A1 generally give rise to severe and often lethal phenotypes[60]. Replacing glycine with serine results in phenotypes ranging in severity from mild to severe, while substituting glycine with non-serine amino acids generally leads to more severe phenotypes such as achondrogenesis type II, hypochondrogenesis, or SEDC, often accompanied by severe coxa vara[60]. Non-glycine missense mutations involving substitution of arginine with cysteine (e.g., Arg275Cys) result in mild phenotypes characterized by either normal or short stature[60].

For SEMD-S specifically, several documented mutations have been characterized. A glycine-to-aspartic acid substitution at codon 262 (Gly262Asp) in exon 20 has been identified in a three-generation family with SEMD-S[25][28]. Previous autosomal dominant mutations causing SEMD-S have typically substituted an obligate glycine within the triple helix, particularly at codons 292, 304, and 709, with a recurrent glycine substitution at codon 154 identified in Finnish cases[25][28]. Additionally, novel variants including splicing variants (c.1023+2T>C), and missense variants (p.Gly465Asp, p.Gly855Asp, p.Gly669Ala) have been identified in recent case series of patients with SEMD-S and related COL2A1-associated dysplasias[9][60].

Therapeutic Implications and Current Management

Current management of SEMD-S is primarily supportive and symptomatic, as no cure for the underlying genetic defect has been established. Orthopedic management focuses on monitoring and treating spinal deformities, with surgical stabilization sometimes necessary for severe kyphoscoliosis or atlantoaxial instability to prevent spinal cord damage. Physical therapy and orthotic devices may help manage mobility and prevent progressive deformity. Ophthalmologic care is essential, with regular screening for retinal detachment and management of myopia to preserve vision. Pulmonary management of respiratory compromise secondary to severe spinal deformity may include non-invasive ventilation support.

Recent investigations have explored growth hormone therapy in individuals with COL2A1-related dysplasias, including SEMD-S. Among five patients with confirmed COL2A1 mutations who received growth hormone therapy, a mean improvement of approximately +0.61 in height standard deviation score was achieved, indicating modest benefits in growth rate and final height[60]. However, close monitoring of adverse reactions such as progressive scoliosis is required in these patients.

Emerging therapeutic strategies target the molecular pathophysiology of type II collagenopathies. As noted previously, pharmacological inhibition of PERK signaling and the integrated stress response pathway has been shown to prevent differentiation defects and ameliorate chondrodysplasia in mouse models of metaphyseal chondrodysplasia Schmid type[32]. Similar therapeutic approaches targeting the ER stress response pathway may prove beneficial in SEMD-S and warrant further investigation. Additionally, strategies to enhance the folding and secretion of mutant collagen, or to promote the synthesis of sufficient normal collagen to overcome the effects of the mutant protein, represent potential therapeutic avenues for future exploration.

Inheritance Pattern and Genetic Counseling

SEMD-S is inherited in an autosomal dominant pattern, meaning that a single copy of the altered COL2A1 gene in each cell is sufficient to cause the disorder[1][3][19]. Most cases result from de novo (newly occurring) mutations in individuals with no prior family history of the condition, as happened in approximately 85-90% of cases in recent case series[9][60]. In families with de novo mutations, the affected parent typically has extremely low recurrence risk for future offspring, barring gonadal mosaicism. However, when an affected parent carries the mutation, there is a 50% chance of transmitting the mutation to each offspring, resulting in an affected child. Genetic counseling should include discussion of these inheritance patterns, discussion of the progressive nature of the condition, overview of the variable clinical course, and exploration of reproductive planning options including prenatal diagnosis or preimplantation genetic diagnosis.

Conclusion: Integration of Molecular and Cellular Pathophysiology

Spondyloepimetaphyseal dysplasia Strudwick type represents a complex type II collagenopathy in which a single heterozygous mutation in the COL2A1 gene triggers a cascade of pathophysiological events spanning multiple levels of biological organization. At the molecular level, glycine-to-amino acid substitutions in the critical Gly-X-Y repeats of the collagen triple helix disrupt the precise structural geometry necessary for proper triple helix formation, leading to destabilization of the collagen structure and impaired secretion of the abnormal molecules[5][27]. This molecular defect initiates intracellular retention of misfolded procollagen within the endoplasmic reticulum, triggering ER stress and activation of the unfolded protein response[8][34].

At the cellular level, the ER stress activates the PERK/eIF2α/ATF4/CHOP signaling cascade, leading to global reduction in protein synthesis, aberrant chondrocyte differentiation through ectopic SOX9 expression, and ultimately programmed cell death through apoptotic mechanisms[32][34][35]. The resulting loss of proliferating chondrocytes and disruption of normal chondrocyte differentiation impairs the Ihh-PTHrP signaling axis and VEGF-mediated angiogenesis, both essential for the orderly progression of endochondral ossification[16][36][45][50].

At the tissue and organismal level, this disruption of endochondral ossification culminates in severe skeletal dysplasia characterized by profound dwarfism with disproportionate short trunk and limbs, progressive spinal deformities, characteristic metaphyseal dysplasia, ocular complications secondary to abnormal vitreous structure, and premature joint degenerative disease. The progressive nature of the spinal deformities predisposes to restrictive lung disease and secondary respiratory complications. Understanding this multi-level pathophysiology provides a framework for comprehending the varied clinical manifestations of SEMD-S and offers potential targets for future therapeutic interventions aimed at modulating ER stress responses, promoting chondrocyte survival and differentiation, or enhancing the synthesis and secretion of normal type II collagen.